EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 02017R2470-20240501

Consolidated text: Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (Text with EEA relevance)Text with EEA relevance

ELI: http://data.europa.eu/eli/reg_impl/2017/2470/2024-05-01

02017R2470 — EN — 01.05.2024 — 046.001


This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

►B

COMMISSION IMPLEMENTING REGULATION (EU) 2017/2470

of 20 December 2017

establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods

(Text with EEA relevance)

(OJ L 351 30.12.2017, p. 72)

Amended by:

 

 

Official Journal

  No

page

date

 M1

COMMISSION IMPLEMENTING REGULATION (EU) 2018/460 of 20 March 2018

  L 78

2

21.3.2018

 M2

COMMISSION IMPLEMENTING REGULATION (EU) 2018/461 of 20 March 2018

  L 78

7

21.3.2018

 M3

COMMISSION IMPLEMENTING REGULATION (EU) 2018/462 of 20 March 2018

  L 78

11

21.3.2018

 M4

COMMISSION IMPLEMENTING REGULATION (EU) 2018/469 of 21 March 2018

  L 79

11

22.3.2018

 M5

COMMISSION IMPLEMENTING REGULATION (EU) 2018/991 of 12 July 2018

  L 177

9

13.7.2018

 M6

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1011 of 17 July 2018

  L 181

4

18.7.2018

 M7

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1018 of 18 July 2018

  L 183

9

19.7.2018

 M8

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1032 of 20 July 2018

  L 185

9

23.7.2018

►M9

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1023 of 23 July 2018

  L 187

1

24.7.2018

►M10

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1122 of 10 August 2018

  L 204

36

13.8.2018

►M11

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1123 of 10 August 2018

  L 204

41

13.8.2018

►M12

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1132 of 13 August 2018

  L 205

15

14.8.2018

►M13

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1133 of 13 August 2018

  L 205

18

14.8.2018

 M14

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1293 of 26 September 2018

  L 243

2

27.9.2018

►M15

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1631 of 30 October 2018

  L 272

17

31.10.2018

 M16

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1632 of 30 October 2018

  L 272

23

31.10.2018

►M17

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1633 of 30 October 2018

  L 272

29

31.10.2018

►M18

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1647 of 31 October 2018

  L 274

51

5.11.2018

 M19

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1648 of 29 October 2018

  L 275

1

6.11.2018

►M20

Amended by:  COMMISSION IMPLEMENTING REGULATION (EU) 2023/65 of 6 January 2023

  L 6

1

9.1.2023

►M21

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1991 of 13 December 2018

  L 320

22

17.12.2018

►M22

COMMISSION IMPLEMENTING REGULATION (EU) 2018/2016 of 18 December 2018

  L 323

1

19.12.2018

►M23

COMMISSION IMPLEMENTING REGULATION (EU) 2018/2017 of 18 December 2018

  L 323

4

19.12.2018

►M24

COMMISSION IMPLEMENTING REGULATION (EU) 2019/108 of 24 January 2019

  L 23

4

25.1.2019

►M25

COMMISSION IMPLEMENTING REGULATION (EU) 2019/109 of 24 January 2019

  L 23

7

25.1.2019

►M26

COMMISSION IMPLEMENTING REGULATION (EU) 2019/110 of 24 January 2019

  L 23

11

25.1.2019

►M27

COMMISSION IMPLEMENTING REGULATION (EU) 2019/387 of 11 March 2019

  L 70

17

12.3.2019

 M28

COMMISSION IMPLEMENTING REGULATION (EU) 2019/388 of 11 March 2019

  L 70

21

12.3.2019

 M29

COMMISSION IMPLEMENTING REGULATION (EU) 2019/456 of 20 March 2019

  L 79

13

21.3.2019

►M30

COMMISSION IMPLEMENTING REGULATION (EU) 2019/506 of 26 March 2019

  L 85

11

27.3.2019

►M31

COMMISSION IMPLEMENTING REGULATION (EU) 2019/760 of 13 May 2019

  L 125

13

14.5.2019

►M32

COMMISSION IMPLEMENTING REGULATION (EU) 2019/1272 of 29 July 2019

  L 201

3

30.7.2019

►M33

COMMISSION IMPLEMENTING REGULATION (EU) 2019/1294 of 1 August 2019

  L 204

16

2.8.2019

 M34

COMMISSION IMPLEMENTING REGULATION (EU) 2019/1314 of 2 August 2019

  L 205

4

5.8.2019

►M35

COMMISSION IMPLEMENTING REGULATION (EU) 2019/1686 of 8 October 2019

  L 258

13

9.10.2019

►M36

Amended by:  COMMISSION IMPLEMENTING REGULATION (EU) 2023/65 of 6 January 2023

  L 6

1

9.1.2023

►M37

COMMISSION IMPLEMENTING REGULATION (EU) 2019/1976 of 25 November 2019

  L 308

40

29.11.2019

►M38

COMMISSION IMPLEMENTING REGULATION (EU) 2019/1979 of 26 November 2019

  L 308

62

29.11.2019

 M39

COMMISSION IMPLEMENTING REGULATION (EU) 2019/2165 of 17 December 2019

  L 328

81

18.12.2019

 M40

COMMISSION IMPLEMENTING REGULATION (EU) 2020/16 of 10 January 2020

  L 7

6

13.1.2020

 M41

COMMISSION IMPLEMENTING REGULATION (EU) 2020/24 of 13 January 2020

  L 8

12

14.1.2020

►M42

COMMISSION IMPLEMENTING REGULATION (EU) 2020/206 of 14 February 2020

  L 43

66

17.2.2020

►M43

COMMISSION IMPLEMENTING REGULATION (EU) 2020/443 of 25 March 2020

  L 92

7

26.3.2020

►M44

COMMISSION IMPLEMENTING REGULATION (EU) 2020/478 of 1 April 2020

  L 102

1

2.4.2020

►M45

COMMISSION IMPLEMENTING REGULATION (EU) 2020/484 of 2 April 2020

  L 103

3

3.4.2020

►M46

Amended by:  COMMISSION IMPLEMENTING REGULATION (EU) 2021/1318 of 9 August 2021

  L 286

5

10.8.2021

►M47

COMMISSION IMPLEMENTING REGULATION (EU) 2020/500 of 6 April 2020

  L 109

2

7.4.2020

►M48

COMMISSION IMPLEMENTING REGULATION (EU) 2020/916 of 1 July 2020

  L 209

6

2.7.2020

►M49

COMMISSION IMPLEMENTING REGULATION (EU) 2020/917 of 1 July 2020

  L 209

10

2.7.2020

►M50

COMMISSION IMPLEMENTING REGULATION (EU) 2020/973 of 6 July 2020

  L 215

7

7.7.2020

►M51

COMMISSION IMPLEMENTING REGULATION (EU) 2020/1163 of 6 August 2020

  L 258

1

7.8.2020

►M52

COMMISSION IMPLEMENTING REGULATION (EU) 2020/1559 of 26 October 2020

  L 357

7

27.10.2020

►M53

COMMISSION IMPLEMENTING REGULATION (EU) 2020/1634 of 4 November 2020

  L 367

39

5.11.2020

►M54

COMMISSION IMPLEMENTING REGULATION (EU) 2020/1820 of 2 December 2020

  L 406

29

3.12.2020

►M55

COMMISSION IMPLEMENTING REGULATION (EU) 2020/1821 of 2 December 2020

  L 406

34

3.12.2020

►M56

COMMISSION IMPLEMENTING REGULATION (EU) 2020/1822 of 2 December 2020

  L 406

39

3.12.2020

►M57

COMMISSION IMPLEMENTING REGULATION (EU) 2020/1993 of 4 December 2020

  L 410

62

7.12.2020

►M58

COMMISSION IMPLEMENTING REGULATION (EU) 2021/50 of 22 January 2021

  L 23

7

25.1.2021

►M59

COMMISSION IMPLEMENTING REGULATION (EU) 2021/51 of 22 January 2021

  L 23

10

25.1.2021

►M60

COMMISSION IMPLEMENTING REGULATION (EU) 2021/82 of 27 January 2021

  L 29

16

28.1.2021

►M61

COMMISSION IMPLEMENTING REGULATION (EU) 2021/96 of 28 January 2021

  L 31

201

29.1.2021

►M62

Amended by:  COMMISSION IMPLEMENTING REGULATION (EU) 2023/65 of 6 January 2023

  L 6

1

9.1.2023

►M63

COMMISSION IMPLEMENTING REGULATION (EU) 2021/120 of 2 February 2021

  L 37

1

3.2.2021

►M64

COMMISSION IMPLEMENTING REGULATION (EU) 2021/668 of 23 April 2021

  L 141

3

26.4.2021

►M65

COMMISSION IMPLEMENTING REGULATION (EU) 2021/670 of 23 April 2021

  L 141

14

26.4.2021

►M66

COMMISSION IMPLEMENTING REGULATION (EU) 2021/882 of 1 June 2021

  L 194

16

2.6.2021

 M67

COMMISSION IMPLEMENTING REGULATION (EU) 2021/900 of 3 June 2021

  L 197

71

4.6.2021

 M68

COMMISSION IMPLEMENTING REGULATION (EU) 2021/912 of 4 June 2021

  L 199

10

7.6.2021

►M69

COMMISSION IMPLEMENTING REGULATION (EU) 2021/1318 of 9 August 2021

  L 286

5

10.8.2021

►M70

COMMISSION IMPLEMENTING REGULATION (EU) 2021/1319 of 9 August 2021

  L 286

12

10.8.2021

►M71

COMMISSION IMPLEMENTING REGULATION (EU) 2021/1326 of 10 August 2021

  L 288

24

11.8.2021

 M72

COMMISSION IMPLEMENTING REGULATION (EU) 2021/1377 of 19 August 2021

  L 297

20

20.8.2021

►M73

COMMISSION IMPLEMENTING REGULATION (EU) 2021/1974 of 12 November 2021

  L 402

5

15.11.2021

►M74

COMMISSION IMPLEMENTING REGULATION (EU) 2021/1975 of 12 November 2021

  L 402

10

15.11.2021

►M75

COMMISSION IMPLEMENTING REGULATION (EU) 2021/2029 of 19 November 2021

  L 415

9

22.11.2021

►M76

COMMISSION IMPLEMENTING REGULATION (EU) 2021/2079 of 26 November 2021

  L 426

16

29.11.2021

►M77

COMMISSION IMPLEMENTING REGULATION (EU) 2021/2129 of 2 December 2021

  L 432

13

3.12.2021

►M78

COMMISSION IMPLEMENTING REGULATION (EU) 2021/2191 of 10 December 2021

  L 445

1

13.12.2021

►M79

COMMISSION IMPLEMENTING REGULATION (EU) 2022/47 of 13 January 2022

  L 9

29

14.1.2022

►M80

COMMISSION IMPLEMENTING REGULATION (EU) 2022/168 of 8 February 2022

  L 28

5

9.2.2022

►M81

COMMISSION IMPLEMENTING REGULATION (EU) 2022/169 of 8 February 2022

  L 28

10

9.2.2022

►M82

COMMISSION IMPLEMENTING REGULATION (EU) 2022/187 of 10 February 2022

  L 30

102

11.2.2022

►M83

COMMISSION IMPLEMENTING REGULATION (EU) 2022/188 of 10 February 2022

  L 30

108

11.2.2022

►M84

COMMISSION IMPLEMENTING REGULATION (EU) 2022/196 of 11 February 2022

  L 31

46

14.2.2022

►M85

COMMISSION IMPLEMENTING REGULATION (EU) 2022/202 of 14 February 2022

  L 33

41

15.2.2022

►M86

COMMISSION IMPLEMENTING REGULATION (EU) 2022/672 of 22 April 2022

  L 122

24

25.4.2022

►M87

COMMISSION IMPLEMENTING REGULATION (EU) 2022/673 of 22 April 2022

  L 122

27

25.4.2022

 M88

COMMISSION IMPLEMENTING REGULATION (EU) 2022/684 of 28 April 2022

  L 126

10

29.4.2022

►M89

COMMISSION IMPLEMENTING REGULATION (EU) 2022/961 of 20 June 2022

  L 165

41

21.6.2022

►M90

COMMISSION IMPLEMENTING REGULATION (EU) 2022/965 of 21 June 2022

  L 166

118

22.6.2022

►M91

COMMISSION IMPLEMENTING REGULATION (EU) 2022/966 of 21 June 2022

  L 166

125

22.6.2022

►M92

COMMISSION IMPLEMENTING REGULATION (EU) 2022/1160 of 5 July 2022

  L 179

25

6.7.2022

►M93

COMMISSION IMPLEMENTING REGULATION (EU) 2022/1365 of 4 August 2022

  L 205

230

5.8.2022

►M94

COMMISSION IMPLEMENTING REGULATION (EU) 2022/1373 of 5 August 2022

  L 206

28

8.8.2022

►M95

COMMISSION IMPLEMENTING REGULATION (EU) 2022/1381 of 8 August 2022

  L 207

12

9.8.2022

►M96

COMMISSION IMPLEMENTING REGULATION (EU) 2022/2534 of 21 December 2022

  L 328

85

22.12.2022

►M97

COMMISSION IMPLEMENTING REGULATION (EU) 2022/2535 of 21 December 2022

  L 328

91

22.12.2022

►M98

COMMISSION IMPLEMENTING REGULATION (EU) 2023/4 of 3 January 2023

  L 2

3

4.1.2023

►M99

COMMISSION IMPLEMENTING REGULATION (EU) 2023/5 of 3 January 2023

  L 2

9

4.1.2023

►M100

COMMISSION IMPLEMENTING REGULATION (EU) 2023/6 of 3 January 2023

  L 2

16

4.1.2023

►M101

COMMISSION IMPLEMENTING REGULATION (EU) 2023/7 of 3 January 2023

  L 2

21

4.1.2023

►M102

COMMISSION IMPLEMENTING REGULATION (EU) 2023/52 of 4 January 2023

  L 3

1

5.1.2023

►M103

COMMISSION IMPLEMENTING REGULATION (EU) 2023/58 of 5 January 2023

  L 5

10

6.1.2023

►M104

COMMISSION IMPLEMENTING REGULATION (EU) 2023/65 of 6 January 2023

  L 6

1

9.1.2023

►M105

COMMISSION IMPLEMENTING REGULATION (EU) 2023/113 of 16 January 2023

  L 15

1

17.1.2023

►M106

COMMISSION IMPLEMENTING REGULATION (EU) 2023/267 of 8 February 2023

  L 39

1

9.2.2023

►M107

COMMISSION IMPLEMENTING REGULATION (EU) 2023/463 of 3 March 2023

  L 68

32

6.3.2023

►M108

COMMISSION IMPLEMENTING REGULATION (EU) 2023/652 of 20 March 2023

  L 81

23

21.3.2023

►M109

COMMISSION IMPLEMENTING REGULATION (EU) 2023/667 of 22 March 2023

  L 84

3

23.3.2023

►M110

COMMISSION IMPLEMENTING REGULATION (EU) 2023/859 of 25 April 2023

  L 111

17

26.4.2023

►M111

COMMISSION IMPLEMENTING REGULATION (EU) 2023/931 of 8 May 2023

  L 124

1

10.5.2023

►M112

COMMISSION IMPLEMENTING REGULATION (EU) 2023/937 of 10 May 2023

  L 125

12

11.5.2023

►M113

COMMISSION IMPLEMENTING REGULATION (EU) 2023/938 of 10 May 2023

  L 125

16

11.5.2023

►M114

COMMISSION IMPLEMENTING REGULATION (EU) 2023/943 of 11 May 2023

  L 126

41

12.5.2023

►M115

COMMISSION IMPLEMENTING REGULATION (EU) 2023/948 of 12 May 2023

  L 128

52

15.5.2023

►M116

COMMISSION IMPLEMENTING REGULATION (EU) 2023/949 of 12 May 2023

  L 128

60

15.5.2023

►M117

COMMISSION IMPLEMENTING REGULATION (EU) 2023/950 of 12 May 2023

  L 128

68

15.5.2023

►M118

COMMISSION IMPLEMENTING REGULATION (EU) 2023/951 of 12 May 2023

  L 128

73

15.5.2023

►M119

COMMISSION IMPLEMENTING REGULATION (EU) 2023/961 of 12 May 2023

  L 129

3

16.5.2023

►M120

COMMISSION IMPLEMENTING REGULATION (EU) 2023/972 of 10 May 2023

  L 132

46

17.5.2023

►M121

COMMISSION IMPLEMENTING REGULATION (EU) 2023/1581 of 1 August 2023

  L 194

4

2.8.2023

►M122

COMMISSION IMPLEMENTING REGULATION (EU) 2023/1582 of 1 August 2023

  L 194

8

2.8.2023

►M123

COMMISSION IMPLEMENTING REGULATION (EU) 2023/1583 of 1 August 2023

  L 194

13

2.8.2023

 M124

COMMISSION IMPLEMENTING REGULATION (EU) 2023/2145 of 16 October 2023

  L 2145

1

17.10.2023

►M125

COMMISSION IMPLEMENTING REGULATION (EU) 2023/2210 of 20 October 2023

  L 2210

1

23.10.2023

►M126

COMMISSION IMPLEMENTING REGULATION (EU) 2023/2214 of 23 October 2023

  L 2214

1

24.10.2023

►M127

COMMISSION IMPLEMENTING REGULATION (EU) 2023/2215 of 23 October 2023

  L 2215

1

24.10.2023

►M128

COMMISSION IMPLEMENTING REGULATION (EU) 2023/2847 of 20 December 2023

  L 2847

1

21.12.2023

►M129

COMMISSION IMPLEMENTING REGULATION (EU) 2023/2851 of 20 December 2023

  L 2851

1

21.12.2023

►M130

COMMISSION IMPLEMENTING REGULATION (EU) 2024/1023 of 8 April 2024

  L 1023

1

9.4.2024

►M131

COMMISSION IMPLEMENTING REGULATION (EU) 2024/1026 of 8 April 2024

  L 1026

1

9.4.2024

►M132

COMMISSION IMPLEMENTING REGULATION (EU) 2024/1027 of 8 April 2024

  L 1027

1

9.4.2024

►M133

COMMISSION IMPLEMENTING REGULATION (EU) 2024/1037 of 9 April 2024

  L 1037

1

10.4.2024

►M134

COMMISSION IMPLEMENTING REGULATION (EU) 2024/1046 of 9 April 2024

  L 1046

1

10.4.2024

►M135

COMMISSION IMPLEMENTING REGULATION (EU) 2024/1047 of 9 April 2024

  L 1047

1

10.4.2024

►M136

COMMISSION IMPLEMENTING REGULATION (EU) 2024/1048 of 9 April 2024

  L 1048

1

10.4.2024

►M137

COMMISSION IMPLEMENTING REGULATION (EU) 2024/1052 of 10 April 2024

  L 1052

1

11.4.2024




▼B

COMMISSION IMPLEMENTING REGULATION (EU) 2017/2470

of 20 December 2017

establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods

(Text with EEA relevance)



Article 1

Union list of authorised novel foods

The Union list of novel foods authorised to be placed on the market within the Union as referred to in Article 6(1) of Regulation (EU) 2015/2283 is hereby established and set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

▼M9




ANNEX

UNION LIST OF NOVEL FOODS

Content of the list

1. The Union list shall consist of Tables 1 and 2.

2. Table 1 includes the authorised novel foods and contains the following information:

Column 1

:

Authorised novel food

Column 2

:

Conditions under which the novel food may be used. This column is further subdivided into two: Specified food category and Maximum levels

Column 3

:

Additional specific labelling requirements

Column 4

:

Other requirements

3. Table 2 includes the specifications on novel foods and contains the following information:

Column 1

:

Authorised novel food

Column 2

:

Specifications



Table 1: Authorised novel foods

Authorised novel food

Conditions under which the novel food may be used

Additional specific labelling requirements

Other requirements

►M30  Data Protection ◄

N-Acetyl-D-neuraminic acid

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘N-acetyl-D-neuraminic acid’

Food supplements containing N-acetyl-D-neuraminic acid shall bear a statement that the food supplement should not be given to infants, young children and children under 10 years of age where they consume breast milk or other foods with added N-acetyl-D-neuraminic acid within the same twenty four hour period.

 

 

Infant and follow-on formulae as defined by Regulation (EU) No 609/2013 (1)

0,05 g/L of reconstituted formula

Processed cereal-based foods and baby foods for infants and young children as defined by Regulation (EU) No 609/2013

0,05 g/kg for solid foods

Foods for special medical purposes for infants and young children as defined by Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than the maximum levels specified for the category mentioned in the table corresponding to the products.

Total diet replacement foods for weight control as defined by Regulation (EU) No 609/2013

0,2 g/L (drinks)

1,7 g/kg (bars)

Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014 (2)

1,25 g/kg

Unflavoured pasteurised and sterilised (including UHT) milk-based products

0,05 g/L

Unflavoured fermented milk-based products, heat treated after fermentation, flavoured fermented milk products including heat-treated products

0,05 g/L (beverages)

0,4 g/kg (solids)

Dairy analogues, including beverage whiteners

0,05 g/L (beverages)

0,25 g/kg (solids)

Cereal bars

0,5 g/kg

Table top sweeteners

8,3 g/kg

Fruit and vegetable-based drinks

0,05 g/L

Flavoured drinks

0,05 g/L

Speciality coffee, tea, herbal and fruit infusions, chicory; tea, herbal and fruit infusions and chicory extracts; tea, plant, fruit and cereal preparations for infusions

0,2 g/kg

Food Supplements as defined in Directive 2002/46/EC (3)

300 mg/day for general population older than 10 years

55 mg/day for infants

130 mg/day for young children

250 mg/day for children between 3 to 10 years of age

▼M99

Acheta domesticus (house cricket) partially defatted powder

Specified food category

Maximum levels (g/100 g)(marketed as such or reconstituted according to the instructions)

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Acheta domesticus (house cricket) partially defatted powder’.

2.  The labelling of the foodstuffs containing Acheta domesticus (house cricket) partially defatted powder shall bear a statement that this ingredient may cause allergic reactions to consumers with known allergies to crustaceans, molluscs, and products thereof, and to dust mites.

This statement shall appear in close proximity to the list of ingredients.

 

Authorised on 24.1.2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: ‘Cricket One Co. Ltd’, 383/3/51 Quang Trung street, Ward 10, Go Vap district, Ho Chi Minh City, Vietnam.

During the period of data protection, the novel food Acheta domesticus (house cricket) partially defatted powder is authorised for placing on the market within the Union only by ‘Cricket One Co. Ltd’, unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283, or with the agreement of ‘Cricket One Co. Ltd’.

End date of the data protection: 24.1.2028.

Multigrain bread and rolls; crackers and breadsticks

2

Cereal bars

3

Pre-mixes for baked products (dry)

3

Biscuits

1,5

Pasta-based products (dry)

0,25

Stuffed pasta-based products (dry)

3

Sauces

1

Processed potato products, legume- and vegetable-based dishes, pizza, pasta-based dishes

1

Whey powder

3

Meat analogues

5

Soups and soup concentrates or powders

1

Maize flour based snacks

4

Beer-like beverages

0,1

Chocolate confectionary

2

Nuts and oilseeds

2

Snacks other than chips

5

Meat preparations

2

 

▼M9

Adansonia digitata (Baobab) dried fruit pulp

Not specified

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Baobab fruit pulp’

 

 

▼M103

Frozen, paste, dried and powder forms of Alphitobius diaperinus larvae (lesser mealworm)

Specified food category

Maximum levels (g/100g)

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Frozen/paste Alphitobius diaperinus larvae (lesser mealworm)’ or ‘Dried/powder Alphitobius diaperinus larvae (lesser mealworm)’ depending on the form used.

2.  The labelling of food supplements containing the novel food shall bear a statement that those food supplements should not be consumed by persons under 18 years of age.

3.  The labelling of the foodstuffs containing frozen, paste, dried or powder forms of Alphitobius diaperinus larvae (lesser mealworm) shall bear a statement that this ingredient may cause allergic reactions to consumers with known allergies to crustaceans, and products thereof, and to dust mites.

This statement shall appear in close proximity to the list of ingredients.

 

Authorised on 26.1.2023. This inclusion is based on proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Ynsect NL B.V, Harderwijkerweg 141B, 3852 AB Ermelo, the Netherlands.

During the period of data protection, the novel food is authorised for placing on the market within the Union only by Ynsect NL B.V., unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283, or with the agreement of Ynsect NL B.V.

End date of the data protection: 26.1.2028.

Cereal bars

25 (Dried form)

25 (Powder form)

Bread and rolls

20 (Powder form)

Processed and breakfast cereals

10 (Dried form)

10 (Powder form)

Porridge

15 (Powder form)

Pre-mixes (dry) for baked products

10 (Powder form)

Dried pasta-based products

10 (Powder form)

Stuffed pasta-based products

28 (Frozen or paste form)

10 (Powder form)

Whey powder

35 (Powder form)

Soups

15 (Powder form)

Cereal-, pasta-based dishes

5 (Powder form)

Pizza-based dishes

5 (Dried form)

5 (Powder form)

Noodles

10 (Powder form)

Snacks other than chips

10 (Dried form)

10 (Powder form)

Chips/crisps

10 (Powder form)

Crackers and bread sticks

10 (Powder form)

Peanut butter

15 (Powder form)

Ready-to-eat savoury based sandwich

20 (Powder form)

Meat preparations

14 (Frozen or paste form)

5 (Powder form)

Meat analogues

40 (Frozen or paste form)

15 (Powder form)

Milk and dairy analogues

10 (Powder form)

Chocolate confectionary

5 (Powder form)

Food supplements as defined in Directive 2002/46/EC for the adult population

4 g/day (Powder form)

▼M9

Ajuga reptans extract from cell cultures

Specified food category

Maximum levels

 

 

 

Food Supplements as defined in Directive 2002/46/EC

In line with normal use in food supplements of a similar extract of the flowering aerial parts of Ajuga reptans

▼M80

Akkermansia muciniphila (pasteurised)

Foods for special medical purposes as defined under Regulation (EU) No 609/2013 for the adult population, excluding pregnant and lactating women

3,4 × 1010 cells/day

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘pasteurised Akkermansia muciniphila’.

 

Authorised on 1 March 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: A-Mansia Biotech S.A., rue Granbonpré, 11, Bâtiment H, 1435 Mont-Saint-Guibert. Belgium. During the period of data protection, the novel food pasteurised Akkermansia muciniphila is authorised for placing on the market within the Union only by A-Mansia Biotech S.A., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Mansia Biotech S.A.

End date of the data protection: 1 March 2027.

Food supplements as defined in Directive 2002/46/EC for the adult population, excluding pregnant and lactating women

3,4 × 1010 cells/day

The labelling of food supplements containing pasteurised Akkermansia muciniphila shall bear a statement that they should be consumed by adults only, excluding pregnant and lactating women.

▼M9

L-Alanyl-L-Glutamine

Specified food category

Maximum levels

 

 

 

Food Supplements as defined in Directive 2002/46/EC

 

Foods for special medical purposes as defined in Regulation (EU) No 609/2013 excluding foods for infants and young children

Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen

Algal oil from the microalgae Ulkenia sp.

Specified food category

Maximum levels of DHA

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the micro-algae Ulkenia sp.

 

 

Bakery products (breads, rolls and sweet biscuits)

200 mg/100 g

Cereal bars

500 mg/100 g

Non-alcoholic beverages (including milk based beverages)

60 mg/100 ml

▼M26

Allanblackia seed oil

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Allanblackia seed oil’

 

 

Yellow fat spreads and cream based spreads

30 g/100 g

Mixtures of vegetable oils (*) and milk (falling under the food category: Dairy analogues, including beverage whiteners)

30 g/100 g

(*)  Except olive oils and olive pomace oils as defined in Part VIII of Annex VII of Regulation (EU) No 1308/2013.

▼M9

Aloe macroclada Baker leaf extract

Specified food category

Maximum levels

 

 

 

Food Supplements as defined in Directive 2002/46/EC

In line with normal use in food supplements of the similar gel derived from Aloe vera (L.) Burm.

Antarctic Krill oil from Euphausia superba

Specified food category

Maximum levels of combined DHA and EPA

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lipid extract from the crustacean Antarctic Krill (Euphausia superba)’

 

 

Dairy products except milk-based drinks

200 mg/100 g or for cheese products 600 mg/100 g

Dairy analogues except drinks

200 mg/100 g or for analogues to cheese products 600 mg/100 g

Non-alcoholic beverages

Milk-based drinks

Dairy analogue drinks

80 mg/100 ml

Spreadable fat and dressings

600 mg/100 g

Cooking fats

360 mg/100 ml

Breakfast cereals

500 mg/100 g

Bakery products (breads, rolls and sweet biscuits)

200 mg/100 g

Nutrition bars/cereal bars

500 mg/100 g

Food Supplements as defined in Directive 2002/46/EC

3 000 mg/day for the general population

450 mg/day for pregnant and lactating women

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

250 mg/meal

Processed cereal-based food and baby food intended for infants and young children covered by Regulation (EU) No 609/2013

200 mg/100 ml

Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen

Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014

Antarctic Krill oil rich in phospholipids from Euphausia superba

Specified food category

Maximum levels of combined DHA and EPA

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lipid extract from the crustacean Antarctic Krill (Euphausia superba)’

 

 

Dairy products except milk-based drinks

200 mg/100 g or for cheese products 600 mg/100 g

Dairy analogues except drinks

200 mg/100 g or for analogues to cheese products 600 mg/100 g

Non-alcoholic beverages

Milk-based drinks

Dairy analogue drinks

80 mg/100 ml

Spreadable fat and dressings

600 mg/100 g

Cooking fats

360 mg/100 ml

Breakfast cereals

500 mg/100 g

Bakery products (breads, rolls and sweet biscuits)

200 mg/100 g

Nutrition bars/cereal bars

500 mg/100 g

Food Supplements as defined in Directive 2002/46/EC

3 000 mg/day for the general population

450 mg/day for pregnant and lactating women

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

250 mg/meal

Processed cereal-based food and baby food intended for infants and young children covered by Regulation (EU) No 609/2013

200 mg/100 ml

Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen

Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014

▼M97

Antrodia camphorata mycelia powder

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of food supplements containing it shall be ‘Antrodia camphorata mycelia powder’.

2.  The labelling of the food supplements containing Antrodia camphorata mycelia powder shall bear a statement that this food supplement should not be consumed by infants, children, and adolescents younger than 14 years of age.

 

 

Food supplements as defined in Directive 2002/46/EC, excluding infants, children, and adolescents younger than 14 years of age

990 mg/day

▼M120

Aqueous ethanolic extract of Labisia pumila

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘aqueous ethanolic extract of Labisia pumila’.

2.  The labelling of food supplements containing the novel food shall bear a statement that they should only be consumed by persons above 18 years of age excluding pregnant and lactating women.

 

Authorised on 6 June 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Medika Natura Sdn. Bhd., No. 44B Jalan Bola Tampar 13/14 Section 13, 40100 Shah Alam Selangor, Malaysia. During the period of data protection, the novel food aqueous ethanolic extract of Labisia pumila is authorised for placing on the market within the Union only by Medika Natura Sdn. Bhd., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Medika Natura Sdn. Bhd.

End date of the date protection: 6 June 2028.

Food supplements as defined in Directive 2002/46/EC for the adult population, excluding pregnant and lactating women

350 mg/day

▼M128

Apple fruit cell culture biomass

Specified food category

Maximum levels

 

 

 

Food supplements as defined in Directive 2002/46/EC for the adult population

0,15 mg/day

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘apple fruit cell culture biomass’.

2.  The labelling of food supplements containing the novel food shall bear a statement that they should only be consumed by persons above 18 years of age.

▼M46 M69

Arachidonic acid-rich oil from the fungus Mortierella alpina

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from Mortierella alpina’ or ‘Mortierella alpina oil’

 

 

Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Foods for special medical purposes for infants as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

▼M9

Argan oil from Argania spinosa

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Argan oil’ and if used as seasoning ‘Vegetable oil only for seasoning’ shall be mentioned on the label

 

 

As seasonings

Not specified

Food Supplements as defined in Directive 2002/46/EC

In line with normal food use of vegetable oils

▼M121

Astaxanthin-rich oleoresin from Haematococcus pluvialis algae

Specified food category

Maximum levels of astaxanthin

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Astaxanthin rich oleoresin from Haematococcus pluvialis algae’

The labelling of food supplements containing Astaxanthin rich oleoresin from Haematococcus pluvialis algae shall bear a statement that they should not be consumed:

(a)  if other food supplements containing astaxanthin esters are consumed on the same day

(b)  by infants and young children under 3 years of age

(c)  by infants and children under 10 years of age (12)

(d)  by infants, children and adolescents under 14 years of age (12).

 

 

Food supplements as defined in Directive 2002/46/EC excluding infants and young children

2,3 mg astaxanthin per day for children 3 to less than 10 years of age

5,7 mg astaxanthin per day for adolescents 10 to less than 14 years of age

8 mg astaxanthin per day for general population older than 14 years of age

▼M129

Partially hydrolysed protein from spent barley (Hordeum vulgare) and rice (Oryza sativa)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Partially hydrolysed protein from spent barley and rice’.

In accordance with Article 21 to Regulation (EU) No 1169/2011.

 

Authorised on 10 January 2024. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Evergrain LLC, 3205 S. 9th St, St. Louis, Missouri, 63118 USA. During the period of data protection, the novel food partially hydrolysed protein from spent barley (Hordeum vulgare) and rice (Oryza sativa) is authorised for placing on the market within the Union only by Evergrain LLC, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Evergrain LLC.

End date of the date protection: 10 January 2029.

Fried or extruded cereal, seed or root-based products

5 g/100 g

Confectionery including chocolate

5 g/100 g

Breakfast cereals

5 g/100 g

Pastas and rice (or other cereal)-based dishes

8 g/100 g

Soups (dry mixture)

50 g/100 g

Soups (ready-to-eat)

5 g/100 g

Sauces

10 g/100 g

Dried sauce preparation

50 g/100 g

Meat analogues

15 g/100 g

Cereal bars

30 g/100 g

Butter and margarine/oil blends

10 g/100 g

Milk analogues based ice creams

10 g/100 g

Milk analogues

5 g/100 ml

Nut/seeds paste/emulsion

15 g/100 g

Energy drinks

8 g/100 ml

Soft drinks marketed in relation to physical exercise

5 g/100 ml

Cola type drinks

5 g/100 g

Powdered drink bases

90 g/100 g

Beverages based on fruit and/or vegetable juices

5 g/100 ml

Cream, cheese and yoghurt (non-soy) analogues

10 g/100 g

Hummus

10 g/100 g

Alcohol-free beer

5 g/100 ml

Meal replacement for weight control

30 g/100 g

▼M9

Basil seeds (Ocimum basilicum)

Specified food category

Maximum levels

 

 

 

Fruit juice and fruit/vegetable blend beverages

3 g/200 ml for addition of whole basil seeds (Ocimum basilicum)

▼M134

Beta-glucan from Euglena gracilis microalgae

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘beta-glucan from Euglena gracilis microalgae’.

 

Authorised on 30 April 2024. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Kemin Foods L.C., 1900 Scott Avenue Des Moines, IA 50317, United States. During the period of data protection, the novel food beta-glucan from Euglena gracilis microalgae is authorised for placing on the market within the Union only by Kemin Foods L.C., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Kemin Foods L.C.

End date of the date protection 30 April 2029.

Cereal bars

670 mg/100 g

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013

600 mg/day

Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

100 mg/day for children from 3 to 9 years of age

150 mg/day for children from 10 to 17 years of age

200 mg/day for adults

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘beta-glucan from Euglena gracilis microalgae’.

2.  The labelling of food supplements containing the novel food shall bear a statement that they should only be consumed by persons above 3 years of age/above 9 years of age/adults, depending on the age group the product is intended for

▼M33

Betaine

Specified food category

Maximum levels (7)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘betaine’.

The labelling of foods containing betaine shall bear a statement that the foods should not be used if food supplements containing betaine are consumed the same day.

 

Authorised on 22 August 2019. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: DuPont Nutrition Biosciences ApS, Langebrogade 1 Copenhagen K, DK-1411, Denmark. During the period of data protection, the novel food betaine is authorised for placing on the market within the Union only by DuPont Nutrition Biosciences ApS unless a subsequent applicantobtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of DuPont Nutrition Biosciences ApS,

End date of the data protection: 22 August 2024.

Drink powders, isotonic and energy drinks intended for sportsmen

60 mg/100 g

Protein and cereal bars intended for sportsmen

500 mg/100 g

Meal replacements intended for sportsmen

20 mg/100 g

Total diet replacement for weight control as defined under Regulation (EU) No 609/2013

500 mg/100 g (bar)

136 mg/100 g (soup)

188 mg/100 g (porridge)

60 mg/100 g (beverages)

Foods for Special Medical Purposes as defined under Regulation (EU) No 609/2013 for adults

400 mg/day

▼M9

Fermented black bean extract

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fermented black bean (Soya) extract’’ or ‘Fermented Soya extract’

 

 

Food Supplements as defined in Directive 2002/46/EC

4,5 g/day

Bovine lactoferrin

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lactoferrin from cows’ milk’

 

 

Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013 (ready to drink)

100 mg/100 ml

Foods on dairy basis intended for young children (ready to eat/drink)

200 mg/100 g

Processed cereal food (solid)

670 mg/100 g

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

Depending on the needs of the individual up to 3 g/day

Beverages based on milk

200 mg/100 g

Powdered drink mixes based on milk (ready to drink)

330 mg/100 g

Beverages based on fermented milk (including yoghurt drinks)

50 mg/100 g

Non-alcoholic drinks

120 mg/100 g

Products based on yoghurt

80 mg/100 g

Products based on cheese

2 000 mg/100 g

Ice cream

130 mg/100 g

Cakes and pastries

1 000 mg/100 g

Candies

750 mg/100 g

Chewing gum

3 000 mg/100 g

▼M20 M36 M62 M104

Bovine milk basic whey protein isolate

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Milk whey protein isolate’.

Food supplements containing bovine milk basic whey protein isolate shall bear the following statement:

‘This food supplement should not be consumed by infants/children/adolescents under the age of one/three/eighteen (*) years’

(*)  Depending on the age group the food supplement is intended for.

 

Authorised on 20 November 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283. Applicant: Armor Protéines S.A.S., 19 bis, rue de la Libération 35460 Saint-Brice-en-Coglès, France. During the period of data protection the novel food bovine milk basic whey protein isolate is authorised for placing on the market within the Union only by Armor Protéines S.A.S. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Armor Protéines S.A.S. End date of the data protection: 20 November 2023.

Infant formulae as defined in Regulation (EU) No 609/2013

30 mg/100 g (powder)

3,9 mg/100 mL (reconstituted)

Follow-on formulae as defined in Regulation (EU) No 609/2013

30 mg/100 g (powder)

4,2 mg/100 mL (reconstituted)

Total diet replacement foods for weight control as defined in Regulation (EU) No 609/2013

300 mg/day

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

30 mg/100 g (powder formula for infants during the first months of life until the introduction of appropriate complementary feeding)

3,9 mg/100 mL (reconstituted formula for infants during the first months of life until the introduction of appropriate complementary feeding)

30 mg/100 g (powder formula for infants when appropriate complementary feeding is introduced)

4,2 mg/100 mL (reconstituted formula for infants when appropriate complementary feeding is introduced)

58 mg/day for young children

380 mg/day for children and adolescents from 3 to 18 years of age

610 mg/day for adults

Food supplements as defined in Directive 2002/46/EC

25 mg/day for infants

58 mg/day for young children

250 mg/day for children and adolescents from 3 to 18 years of age

610 mg/day for adults

▼M96

Bovine milk beta-lactoglobulin (β-lactoglobulin)

Specified food category

Maximum levels (g NF/100 ml)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘bovine milk beta-lactoglobulin’ or ‘bovine milk β-lactoglobulin’.

 

Authorised on 11 January 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Arla Foods Ingredients Group P/S, Sønderhøj 10-12, 8260 Viby J, Denmark. During the period of data protection, the novel food beta-lactoglobulin (β-lactoglobulin) is authorised for placing on the market within the Union only by Arla Foods Ingredients Group P/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Arla Foods Ingredients Group P/S.

End date of the data protection: 11 January 2028.

Soft drinks marketed in relation to physical exercise

25

Whey powder (reconstituted)

8

Milk based drinks and similar products

12

Foods for special medical purposes as defined in Regulation (EU) No 609/2013 intended for the general population older than 3 years of age, excluding pregnant and lactating women

In accordance with the particular nutritional requirements of the persons for whom the products are intended

▼M107

Bovine milk osteopontin

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Bovine milk Osteopontin’.

 

Authorised on 26 March 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Arla Foods Ingredients Group P/S., Sønderhøj 10-12 8260 Viby J Denmark. During the period of data protection, the novel food Bovine milk osteopontin is authorised for placing on the market within the Union only by Arla Foods Ingredients Group P/S., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Arla Foods Ingredients Group P/S.

End date of the data protection: 26 March 2028.

Infant formula as defined in Regulation (EU) No 609/2013 (13)

151 mg/L in the final product ready for use,

marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined in Regulation (EU) No 609/2013 (13)

151 mg/L in the final product ready for use,

marketed as such or reconstituted as instructed by the manufacturer

Milk-based drinks intended for young children

151 mg/L in the final product ready for use,

marketed as such or reconstituted as instructed by the manufacturer

▼M9

Buglossoides arvensis seed oil

Specified food category

Maximum levels of stearidonic acid (STA)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Refined Buglossoides oil’

 

 

Dairy products and analogues

250 mg/100 g

75 mg/100 g for drinks

Cheese and cheese products

750 mg/100 g

Butter and other fat and oil emulsions including spreads (not for cooking or frying purposes)

750 mg/100 g

Breakfast cereals

625 mg/100 g

Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

500 mg/day

Foods for special medical purposes as defined in Regulation (EU) No 609/2013, excluding foods for special medical purposes intended for infants and young children

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

250 mg/meal

▼M91

Calanus finmarchicus oil

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘oil from Calanus finmarchicus (crustacean)’.

2.  The labelling of food supplements containing Calanus finmarchicus oil shall bear a statement that those food supplements should not be consumed:

a)  if other food supplements containing astaxanthin esters are consumed on the same day.

b)  by infants and children younger than 3 years.

c)  by children younger than 14 years, if the ingredient contains ≥ 0,1 % astaxanthin.

 

 

Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

1,0 g/day (< 0,1 % astaxanthin esters, resulting in < 1,0 mg astaxanthin per day) for the general population, excluding infants and young children

2,3 g/day (from 0,1 % to ≤ 0,25 % astaxanthin esters, resulting in ≤ 5,75 mg astaxanthin per day) for the general population older than 14 years of age

▼M77

Calcium fructoborate

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘calcium fructoborate’.

2.  The labelling of food supplements containing calcium fructoborate shall bear a statement that those food supplements should not be consumed by population under 18 years of age and by pregnant and lactating women.

 

Authorised on 23 December 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: VDF FutureCeuticals, Inc., 300 West 6th Street Momence, Illinois 60954, the United States.

During the period of data protection, the novel food calcium fructoborate is authorised for placing on the market within the Union only by VDF FutureCeuticals, Inc., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of VDF FutureCeuticals, Inc.

End date of the date protection: 23 December 2026

Food supplements as defined in Directive 2002/46/EC for the adult population, excluding food supplements for pregnant and lactating women

220 mg/day

▼M85

Calcium L-Methylfolate

Specified food category

Maximum levels (expressed as folic acid)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Calcium L-Methylfolate’.

 

 

Foods for special medical purposes and total diet replacement for weight control as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Infant formulae and follow-on formula as defined by Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Processed cereal-based foods and baby foods for infants and young children as defined by Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Food supplements as defined in Directive 2002/46/EC

In accordance with Directive 2002/46/EC

Food fortified in accordance with Regulation (EC) No 1925/2006

In accordance with Regulation (EC) No 1925/2006

▼M137

Calcidiol monohydrate

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘calcidiol (calcifediol) monohydrate (vitamin D)’.

2.  The labelling of food supplements containing the novel food shall bear a statement that they should not be consumed by infants and children under 3 years of age/children under 11 years of age, depending on the age group the product is intended for.

 

Authorised on 1 May 2024. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: DSM Nutritional Products Ltd., Wurmisweg 576, 4303 Kaiseraugst, Switzerland. During the period of data protection, the novel food calcidiol monohydrate is authorised for placing on the market within the Union only by DSM Nutritional Products Ltd., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of DSM Nutritional Products Ltd.

End date of the date protection: 1 May 2029.

Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

10 μg/day for children from 11 years of age and adults

5 μg/day for children from 3 to 10 years of age

▼M106

Dried nuts of Canarium ovatum Engl.

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘nuts of Canarium ovatum’ and/or ‘pilinuts’ and/or ‘pili (Canarium ovatum) nuts’.

2.  The labelling of the foodstuffs containing dried nuts of Canarium ovatum Engl. shall bear a statement that the dried nuts of Canarium ovatum Engl. may cause allergic reactions to consumers with known allergies to cashew and walnut. This statement shall appear in close proximity to the list of ingredients or, in the absence of a list of ingredients, in close proximity to the name of the food.

 

 

Not specified

 

▼M109

Canarium indicum L. dried nuts (Kenari) (Traditional food from a third country)

Specified food category

Maximum levels (g/100 g)

1.  The designation of the traditional food on the labelling of the foodstuffs containing it shall be ‘dried kenari (Canarium indicum) nuts’.

2.  The labelling of the foodstuffs containing dried nuts of Canarium indicum L. shall bear a statement that the nuts may cause allergic reactions to consumers with known allergies to hazel, cashew and pistachio. This statement shall appear in close proximity to the list of ingredients or, in the absence of a list of ingredient, in close proximity to the name of the food.

 

 

Not specified

 

▼M114

Cellobiose

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘cellobiose’.

2.  The labelling of food supplements containing cellobiose shall bear a statement that those food supplements should not be consumed by infants and young children.

 

Authorised on 1 June 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: SAVANNA Ingredients GmbH, Dürener Straße 67, 50189 Elsdorf, Germany. During the period of data protection, the novel food cellobiose is authorised for placing on the market within the Union only by SAVANNA Ingredients GmbH, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of SAVANNA Ingredients GmbH.

End date of the data protection: 1 June 2028.

Food supplements as defined in Directive 2002/46/EC for the general population, excluding infants and young children

3 g/day

Dried, canned-tinned, raw cured (or seasoned), cooked cured (or seasoned) meat

2 g/100 g

Fresh raw, preserved or partly preserved sausages

2 g/100 g

Meat based spreadable-textured specialties

2 g/100 g

Liver based spreadable-textured specialties

2 g/100 g

Savoury sauce dry preparation

40 g/100 g

Table-top sweeteners in powder form

60 g/100 g

Table-top sweeteners in tablets

60 g/100 g

▼M82

Cetylated fatty acids

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the food supplements containing it shall be ‘cetylated fatty acids preparation’.

2.  The labelling of food supplements containing the novel food shall bear a statement that those food supplements should not be consumed by persons under 18 years of age.

 

Authorised on 3 March 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Pharmanutra S.p.A., Via Delle Lenze 216/b, 56122 Pisa, Italy. During the period of data protection, the novel food cetylated fatty acids is authorised for placing on the market within the Union only by Pharmanutra S.p.A., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Pharmanutra S.p.A.

End date of the date protection: 3 March 2027

Food supplements as defined in Directive 2002/46/EC for the adult population

1,6 g/day

▼M9

Chewing gum base (monomethoxypolyethylene glycol)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Gum base (including 1,3-butadiene, 2-methyl-homopolymer, maleated, esters with polyethylene glycol mono-Me ether)’ or ‘Gum base (including CAS No: 1246080-53-4)’

 

 

Chewing gum

8 %

Chewing gum base (Methyl vinyl ether-maleic anhydride copolymer)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Gum base (including methyl vinyl ether-maleic anhydride copolymer)’ or ‘Gum base (including CAS No 9011-16-9)’

 

 

Chewing gum

2 %

Chia oil from Salvia hispanica

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chia oil (Salvia hispanica)’

 

 

Fats and oils

10 %

Pure chia oil

2 g/day

Food Supplements as defined in Directive 2002/46/EC

2 g/day

▼M64

Chia seeds (Salvia hispanica)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chia seeds (Salvia hispanica)’

 

 

Bread products

5 % (whole or ground chia seeds)

Baked products

10 % whole chia seeds

Breakfast cereals

10 % whole chia seeds

Sterilised ready to eat meals based on cereal grains, pseudocereal grains and/or pulses

5 % whole chia seeds

Fruit, nut and seed mixes

 

Chia seeds as such

 

Confectionery (including chocolate and chocolate products), excluding chewing gums

 

Dairy products (including yoghurt) and analogues

 

Edible ices

 

Fruit and vegetables products (including fruit spreads, compotes with/without cereals, fruit-preparations to underlay or to be mixed with dairy products, fruit desserts, mixed fruits with coconut milk for a twin pot)

 

Non-alcoholic beverages (including fruit juice and fruit/vegetable blend beverages)

 

Puddings that do not require heat treatment at or above 120 °C in their manufacture, processing or preparation

 

▼M9

Chitin-glucan from Aspergillus niger

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chitin-glucan from Aspergillus niger

 

 

Food Supplements as defined in Directive 2002/46/EC

5 g/day

Chitin-glucan complex from Fomes fomentarius

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chitin-glucan from Fomes fomentarius

 

 

Food Supplements as defined in Directive 2002/46/EC

5 g/day

Chitosan extract from fungi (Agaricus bisporus; Aspergillus niger)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chitosan extract from Agaricus bisporus’ or ‘Chitosan extract from Aspergillus niger

 

 

Food Supplements as defined in Directive 2002/46/EC

In line with normal use in food supplements of chitosan from crustaceans

Chondroitin sulphate

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chondroitin sulphate derived from microbial fermentation and sulphation’

 

 

Food supplements as defined in Directive 2002/46/EC for adult population, excluding pregnant and lactating women

1 200 mg/day

Chromium Picolinate

Specified food category

Maximum levels of total chromium

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Chromium Picolinate’

 

 

Foods covered by Regulation (EU) No 609/2013

250 μg/day

Foods fortified in accordance with Regulation (EC) No 1925/2006 (4)

▼M56

Chromium-containing yeast (Yarrowia lipolytica) biomass

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘chromium-containing yeast (Yarrowia lipolytica) biomass’

The labelling of food supplements containing chromium-containing yeast (Yarrowia lipolytica) biomass shall bear a statement that the food supplements should not be consumed by infants and young children (children under 3 years of age)/children from 3 to 9 years of age (12).

 

 

Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

2 g/day for children from 3 to 9 years of age, resulting in 46 μg of chromium per day

4 g/day for children from 10 years of age, adolescents and adults, resulting in 92 μg of chromium per day

▼M9

Cistus incanus L. Pandalis herb

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Cistus incanus L. Pandalis herb’

 

 

Herbal infusions

Intended daily intake: 3 g herbs/day (2 cups/day)

Citicoline

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Citicoline’

2.  The labelling of foods containing citicoline shall bear a statement that the product is not intended to be consumed by children

 

 

Food Supplements as defined in Directive 2002/46/EC

500 mg/day

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

250 mg per serving and a maximum daily consumption level of 1 000 mg

Clostridium butyricum

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Clostridium butyricum MIYAIRI 588 (CBM 588)’ or ‘Clostridium butyricum (CBM 588)’

 

 

Food Supplements as defined in Directive 2002/46/EC

1,35 × 108 CFU/day

▼M79

Coffea arabica L. and/or Coffea canephora Pierre ex A.Froehner dried cherry pulp and its infusion (Traditional food from a third country)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘coffee cherry pulp’ and/or ‘cascara (coffee cherry pulp)’, and/or ‘coffee cherry pulp infusion’ and/or ‘coffee cherry pulp dried infusion’.

If the product containing the novel food contains more than 150 mg/l of caffeine (as such or after reconstitution), it shall be labelled with the following indication: ‘High caffeine content. Not recommended for children or pregnant or breast-feeding women’ in the same field of vision as the name of the food, followed by the caffeine content expressed in mg per 100 ml.

Typical infusion preparations are prepared with up to 6 g of coffee cherry pulp per 100 ml of hot water (> 75 °C). For the coffee cherry pulp placed on the market as such for the preparation of infusions, instructions shall be given to the consumer on the preparation.

 

 

Coffee cherry pulp from Coffea arabica L. and/or Coffea canephora Pierre ex A.Froehner for the preparation of infusions

 

Coffee, coffee and chicory extracts, instant coffee, tea, herbal- and fruit-infusions, coffee substitutes, coffee mixes and instant mixes for hot beverages (and their flavoured counterparts).

 

Flavoured and unflavoured non-alcoholic ready-to-drink beverages

 

▼M30

D-ribose

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘D-ribose’.

The labelling of foods containing D-ribose shall bear a statement that the foods should not be used if food supplements containing D-ribose are consumed the same day.

 

Authorised on 16 April 2019. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Bioenergy Life Science, Inc., 13840 Johnson St. NE, Minneapolis, Minnesota, 55304, USA. During the period of data protection, the novel food D-ribose is authorised for placing on the market within the Union only by Bioenergy Life Science, Inc. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Bioenergy Life Science, Inc.

End date of the data protection: 16 April 2024 (5 years).

Cereal bars

0,20 g/100 g

Fine bakery wares

0,31 g/100 g

Chocolate confectionery (excluding chocolate bars)

0,17 g/100 g

Milk-based drinks (excluding malts and shakes)

0,08 g/100 g

Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen, isotonic and energy drinks

0,80 g/100 g

Bars intended to meet the expenditure of intense muscular effort especially for sportsmen

3,3 g/100 g

Meal replacement for weight control (as drinks)'

0,13 g/100 g

Meal replacement for weight control (as bars)

3,30 g/100 g

Confectionery

0,20 g/100 g

Tea and infusions (in powder form to be reconstituted)

0,23 g/100 g

▼M9

Extract of defatted cocoa powder

Specified food category

Maximum levels

Consumers shall be instructed not to consume more than 600 mg polyphenols corresponding to 1,1 g of extract of defatted cocoa powder per day

 

 

Nutrition bars

1 g/day and 300 mg polyphenols corresponding to not more than 550 mg of extract of defatted cocoa powder in one portion of food (or food supplement)

Milk based beverages

Any other foods (including food supplements as defined in Directive 2002/46/EC) which have become established vehicles for functional ingredients and which are typically positioned for consumption by health conscious adults

Low fat cocoa extract

Specified food category

Maximum levels

Consumers shall be instructed not to consume more than 600 mg of cocoa flavanols per day

 

 

Foods including food supplements as defined in Directive 2002/46/EC

730 mg per serving and around 1,2 g/day

Coriander seed oil from Coriandrum sativum

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Coriander seed oil’

 

 

Food Supplements as defined in Directive 2002/46/EC

600 mg/day

▼M15

Cranberry extract powder

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘cranberry extract powder’

 

Authorised on 20 November 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Ocean Spray Cranberries Inc. One Ocean Spray Drive Lakeville-Middleboro, MA, 02349, USA.

During the period of data protection the novel food, cranberry extract powder, is authorised for placing on the market within the Union only by Ocean Spray Cranberries Inc. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Ocean Spray Cranberries Inc.

End date of the data protection: 20 November 2023.

Food Supplements as defined in Directive 2002/46/EC for the adult population

350 mg/day

▼M9

Crataegus pinnatifida dried fruit

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Crataegus pinnatifida dried fruit’

 

 

Herbal infusions

In line with normal food use of Crataegus laevigata

Jams and jellies in accordance with Directive 2001/113/EC (5)

Compotes

α-cyclodextrin

Not specified

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Alpha-cyclodextrin’ or ‘α-cyclodextrin’

 

 

γ-cyclodextrin

Not specified

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Gamma-Cyclodextrin’ or ‘γ-Cyclodextrin’

 

 

▼M22

Decorticated grains of Digitaria exilis (Kippist) Stapf

(Traditional food from a third country)

Not specified

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘decorticated fonio (Digitaria exilis) grains’

 

 

▼M9

Dextran preparation produced by Leuconostoc mesenteroides

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Dextran’

 

 

Bakery products

5 %

Diacylglycerol oil of plant origin

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Diacylglycerol oil of plant origin (at least 80 % diacylglycerols)’

 

 

Cooking oils

 

Fat spreads

Salad dressings

Mayonnaise

Meal replacement for weight control (as drinks)

Bakery products

Yoghurt type products

Dihydrocapsiate (DHC)

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Dihydrocapsiate’

2.  Food supplements containing synthetic dihydrocapsiate will be labelled as ‘not intended for children up to 4.5 years’

 

 

Cereal bars

9 mg/100 g

Biscuits, cookies and crackers

9 mg/100 g

Rice based snacks

12 mg/100 g

Carbonated drinks, dilutable drinks, fruit juice based beverages

1,5 mg/100 ml

Vegetable drinks

2 mg/100 ml

Coffee based drinks, tea based drinks

1,5 mg/100 ml

Flavoured water — still

1 mg/100 ml

Precooked oatmeal cereal

2,5 mg/100 g

Other cereals

4,5 mg/100 g

Ice cream, dairy desserts

4 mg/100 g

Pudding mixes (ready to eat)

2 mg/100 g

Products based on yoghurt

2 mg/100 g

Chocolate confectionery

7,5 mg/100 g

Hard candy

27 mg/100 g

Sugar-free gum

115 mg/100 g

Whitener/creamer

40 mg/100 g

Sweeteners

200 mg/100 g

Soup (ready to eat)

1,1 mg/100 g

Salad dressing

16 mg/100 g

Vegetable protein

5 mg/100 g

Ready to eat meals

3 mg/meal

Meal replacements for weight control

3 mg/meal

Meal replacement for weight control (as drinks)

1 mg/100 ml

Food Supplements as defined in Directive 2002/46/EC

3 mg/single intake

9 mg/day

Non-alcoholic powdered drink mixes

14,5 mg/kg equivalent to 1,5 mg/100 ml

▼M54

Dried Euglena gracilis

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘dried biomass of Euglena gracilis algae’.

The labelling of food supplements containing dried Euglena gracilis shall bear a statement that those food supplements should not be consumed by infants/children under 3 years of age/children under 10 years of age/children and adolescents under 18 years of age (12).

 

Authorised on 23 December 2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Kemin Foods L.C., 2100 Maury Street Des Moines, IA 50317, USA.

During the period of data protection, the novel food is authorised for placing on the market within the Union only by Kemin Foods L.C. unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Kemin Foods L.C.

End date of the data protection: 23 December 2025.

Breakfast cereal bars, granola bars and protein bars

630 mg/100 g

Yoghurt

150 mg/100 g

Yoghurt Beverages

95 mg/100 g

Fruit and vegetable juices, nectars, fruit/vegetable blend beverages

120 mg/100 g

Fruit-Flavoured Drinks

40 mg/100 g

Meal replacement beverages

75 mg/100 g

Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants

100 mg/day for young children

150 mg/day for children from 3 to 9 years of age

225 mg/day for children from 10 years of age and adolescents (to 17 years of age)

375 mg/day for adults

Total diet replacement for weight control as defined by Regulation (EU) No 609/2013

190 mg/meal

▼M13

Dried aerial parts of Hoodia parviflora

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘dried aerial parts of Hoodia parviflora

 

Authorised on 3 September 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Desert Labs, Ltd Kibbutz Yotvata, 88820 Israel.

During the period of data protection the novel food dried aerial parts of Hoodia parviflora is authorised for placing on the market within the Union only by Desert Labs, Ltd unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Desert Labs, Ltd.

End date of the data protection: 3 September 2023.

Food Supplements as defined in Directive 2002/46/EC for adult population

9,4 mg/day

▼M9

Dried extract of Lippia citriodora from cell cultures

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘dried extract of Lippia citriodora from cell cultures HTN®Vb’

 

 

Food Supplements as defined in Directive 2002/46/EC

In line with normal use in food supplements of a similar extract from the leaves of Lippia citriodora

Echinacea angustifolia extract from cell cultures

Specified food category

Maximum levels

 

 

 

Food Supplements as defined in Directive 2002/46/EC

In line with normal use in food supplements of a similar extract from the root of Echinacea angustifolia

▼M32

Echinacea purpurea extract from cell cultures

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘dried extract of Echinacea purpurea from cell cultures EchiPure-PC™’

 

 

Food Supplements as defined in Directive 2002/46/EC

In line with normal use in food supplements of a similar extract from florets within the flower head of Echinacea purpurea

▼M9

Echium plantagineum oil

Specified food category

Maximum levels of stearidonic acid (STA)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Refined echium oil’

 

 

Milk-based products and drinkable yoghurt products delivered in a single dose

250 mg/100 g; 75 mg/100 g for drinks

Cheese preparations

750 mg/100 g

Spreadable fat and dressings

750 mg/100 g

Breakfast cereals

625 mg/100 g

Food supplements as defined in Directive 2002/46/EC

500 mg/day

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

250 mg/meal

▼M52

Ecklonia cava phlorotannins

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Ecklonia cava Phlorotannins’.

Food supplements containing Ecklonia cava phlorotannins shall bear the following statement:

(a)  This food supplement should not be consumed by children/adolescents under the age of twelve/fourteen/eighteen(*) years.

(b)  This food supplement should not be consumed by persons with thyroid disease or by persons who are aware of or have been identified as being at risk of developing thyroid disease.

(c)  This food supplement should not be consumed if other food supplements containing iodine are also consumed.

(*)  Depending on the age group the food supplement is intended for.

 

 

Food supplements as defined in Directive 2002/46/EC intended for the general population, excluding children under the age of 12 years

163 mg/day for adolescents from 12 to 14 years of age

230 mg/day for adolescents above 14 years of age

263 mg/day for adults

▼M18

Egg membrane hydrolysate

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘egg membrane hydrolysate’.

 

Authorised on 25 November 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Biova, LLC., 5800 Merle Hay Rd, Suite 14 PO Box 394 Johnston 50131, Iowa USA. During the period of data protection the novel food egg membrane hydrolysate is authorised for placing on the market within the Union only by Biova, LLC. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Biova, LLC.

End date of the data protection: 25 November 2023

Food Supplements as defined in Directive 2002/46/EC intended for the general adult population

450 mg/day

▼M9

Epigallocatechin gallate as a purified extract from green tea leaves (Camellia sinensis)

Specified food category

Maximum levels

The labelling shall bear a statement that consumers should not consume more than 300 mg of extract per day

 

 

Foods including food supplements as defined in Directive 2002/46/EC

150 mg of extract in one portion of food or food supplement

▼M52

L-ergothioneine

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘L-ergothioneine’

 

 

Alcohol-free beverages

0,025 g/kg

Milk-based drinks

0,025 g/kg

‘Fresh’ milk products(*)

0,040 g/kg

Cereal bars

0,2 g/kg

Chocolate confectionery

0,25 g/kg

Food supplements as defined in Directive 2002/46/EC

30 mg/day for general population (excluding pregnant and lactating women)

20 mg/day for children older than 3 years

(*)  When used in milk products L-ergothioneine may not replace in whole or in part, any milk constituent

▼M108

Roasted and popped kernels from the seeds of Euryale ferox Salisb. (makhana) (Traditional food from a third country)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘roasted seeds of Euryale ferox’ or ‘makhana (Euryale ferox) roasted seeds’

 

 

Processed nuts

 

▼M52

Extract of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz. and Angelica gigas Nakai)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘extract of three herbal roots (Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz. and Angelica gigas Nakai)’.

The labelling of food supplements containing the extract of mixture of the three herbal roots shall bear a statement in close proximity to the list of ingredients indicating that it should not be consumed by individuals with known celery allergy.

 

 

Food supplements as defined in Directive 2002/46/EC for adult population

175 mg/day

▼M9

Ferric Sodium EDTA

Specified food category

Maximum levels (expressed as anhydrous EDTA)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Ferric Sodium EDTA’

 

 

Food supplements as defined in Directive 2002/46/EC

18 mg/day for children

75 mg/day for adults

Foods covered by Regulation (EU) No 609/2013

12 mg/100 g

Foods fortified in accordance with Regulation (EC) No 1925/2006

Ferrous ammonium phosphate

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Ferrous ammonium phosphate’

 

 

Food supplements as defined in Directive 2002/46/EC

To be used in compliance with Directive 2002/46/EC, Regulation (EU) No 609/2013 and/or Regulation (EC) No 1925/2006

Foods covered by Regulation (EU) No 609/2013

Foods fortified in accordance with Regulation (EC) No 1925/2006

Fish peptides from Sardinops sagax

Specified food category

Maximum levels fish peptide product

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fish (Sardinops sagax) peptides’

 

 

Foods based on yoghurt, yoghurt drinks, fermented milk products, and powdered milk

0,48 g/100 g (ready to eat/drink)

Flavoured water, and vegetable-based drinks

0,3 g/100 g (ready to drink)

Breakfast cereals

2 g/100 g

Soups, stews and soup powders

0,3 g/100 g (ready to eat)

Flavonoids from Glycyrrhiza glabra

Specified food category

Maximum levels of flavonoids from Glycyrrhiza glabra

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Flavonoids from Glycyrrhiza glabra L.

2.  The labelling of the foods where the product was added as a novel food ingredient shall bear a statement that:

(a)  the product should not be consumed by pregnant and breast feeding women, children and young adolescents; and

(b)  people taking prescription drugs should only consume the product under medical supervision;

(c)  a maximum of 120 mg of flavonoids per day should be consumed.

3.  The amount of flavonoids in the final food shall be indicated on the labelling of the food containing it.

Beverages containing flavonoids shall be presented to the final consumer as single portions.

 

Beverages based on milk

120 mg/day

Beverages based on yoghurt

Beverages based on fruit or vegetables

Food Supplements as defined in Directive 2002/46/EC

120 mg/day

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013

120 mg/day

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

120 mg/day

▼M42

Fruit pulp, pulp juice, concentrated pulp juice from Theobroma cacao L. (Traditional food from a third country)

Not specified

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘cocoa (Theobroma cacao L.) pulp’, ‘cocoa (Theobroma cacao L.) pulp juice’ or ‘cocoa (Theobroma cacao L.) concentrated pulp juice’ depending on the form used.

 

 

 

▼M9

Fucoidan extract from the seaweed Fucus vesiculosus

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fucoidan extract from seaweed Fucus vesiculosus’.

 

 

Foods including food supplements as defined in Directive 2002/46/EC for the general population

250 mg/day

Fucoidan extract from the seaweed Undaria pinnatifida

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fucoidan extract from seaweed Undaria pinnatifida’

 

 

Foods including food supplements as defined in Directive 2002/46/EC for the general population

250 mg/day

▼M117

2’-Fucosyllactose

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘2′-fucosyllactose’.

2.  The labelling of food supplements containing 2′-fucosyllactose shall bear a statement that the supplements should not be used if other foods with added 2′-fucosyllactose are consumed the same day.

3.  The labelling of food supplements containing 2′-fucosyllactose intended for young children shall bear a statement that the supplements should not be used if breast milk or other foods with added 2′-fucosyllactose are consumed the same day.

 

 

Unflavoured pasteurised and sterilised (including UHT) milk-based products

1,2 g/l

Unflavoured fermented milk-based products

1,2 g/l for beverages

19,2 g/kg for products other than beverages

Flavoured fermented milk-based products including heat-treated products

1,2 g/l for beverages

19,2 g/kg for products other than beverages

Dairy analogues, including beverage whiteners

1,2 g/l for beverages

12 g/kg for products other than beverages

400 g/kg for whitener

Cereal bars

12 g/kg

Table-top sweeteners

200 g/kg

Infant formula as defined under Regulation (EU) No 609/2013

1,2 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

1,2 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based foods and baby foods for infants and young children as defined under Regulation (EU) No 609/2013

12 g/kg for products other than beverages

1,2 g/l for liquid food ready for use, marketed as such or reconstituted as instructed by the manufacturer

Milk based drinks and similar products intended for young children

1,2 g/l for milk-based drinks and similar products in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Foods for special medical purposes as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013

4,8 g/l for drinks

40 g/kg for bars

Bread and pasta products bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Implementing Regulation (EU) No 828/2014

60 g/kg

Flavoured drinks

1,2 g/l

Coffee, tea (excluding black tea), herbal and fruit infusions, chicory; tea, herbal and fruit infusions and chicory extracts; tea, plant, fruit and cereal preparations for infusions, as well as mixes and instant mixes of these products

9,6 g/l – the maximum level refers to the products ready to use

Food supplements as defined in Directive 2002/46/EC, for the general population, excluding infants

3,0 g/day for general population

1,2 g/day for young children

▼M38

2'-Fucosyllactose/Difucosyllactose mixture (‘2'-FL/DFL’)

(microbial source)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘2'-Fucosyllactose/Difucosyllactose mixture’.

The labelling of food supplements containing the 2'-Fucosyllactose/Difucosyllactose mixture shall bear a statement that they should not be used if breast milk or other foods containing added 2'-Fucosyllactose and/or Difucosyllactose are consumed the same day.

 

Authorised on 19.12.2019. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food 2'-Fucosyllactose/Difucosyllactose mixture is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S.

End date of the data protection: 19.12.2024.

Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products

2,0 g/L

Unflavoured fermented milk-based products

2,0 g/L (beverages)

20 g/kg (products other than beverages)

Flavoured fermented milk-based products including heat-treated products

2,0 g/L (beverages)

20 g/kg (products other than beverages)

Beverages (flavoured drinks)

2,0 g/L

Cereal bars

20 g/kg

Infant formula as defined under Regulation (EU) No 609/2013

1,6 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

1,2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based food and baby food for infants and young children as defined under Regulation (EU) No 609/2013

1,2 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

10 g/kg for products other than beverages

Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013

4,0 g/L (beverages)

40 g/kg (products other than beverages)

Food for special medical purposes as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food Supplements as defined in Directive 2002/46/EC intended for the general population excluding infants

4,0 g/day

▼M58

Milk-based drinks and similar products intended for young children

1,2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

▼M75

3-Fucosyllactose (3-FL)

(microbial source)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘3-Fucosyllactose’.

The labelling of food supplements containing 3-Fucosyllactose (3-FL) shall bear a statement that they should not be consumed:

a)  if foods containing added 3-Fucosyllactose are consumed on the same day;

b)  by infants and children under 3 years of age.

 

Authorised on 12 December 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: DuPont Nutrition & Biosciences ApS Langebrogade 1, 1001 Copenhagen K, Denmark. During the period of data protection, the novel food 3-Fucosyllactose is authorised for placing on the market within the Union only by DuPont Nutrition & Biosciences ApS, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of DuPont Nutrition & Biosciences ApS.

End date of the data protection: 12 December 2026.

Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products

0,85  g/L

Unflavoured and flavoured fermented milk-based products including heat-treated products

0,5  g/L (beverages)

5,0  g/kg (products other than beverages)

Dairy analogues

0,85  g/L (beverages)

8,5  g/kg (products other than beverages)

Flavoured drinks, energy and sports drinks

1,0  g/L

Cereal bars

30,0  g/kg

Infant formula as defined under Regulation (EU) No 609/2013

0,85  g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

0,85  g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Milk-based drinks and similar products intended for young children

0,85  g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based food and baby food for infants and young children as defined under Regulation (EU) No 609/2013

0,3  g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

3,0  g/kg for products other than beverages

Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013

2,0  g/L (beverages)

30,0  g/kg (products other than beverages)

Foods for special medical purposes as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food Supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

5,0  g/day

▼M102

3-Fucosyllactose (‘3-FL’)

(produced by a derivative strain of E. coli BL21(DE3))

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘3-fucosyllactose’.

The labelling of food supplements containing 3-Fucosyllactose (3-FL) shall bear a statement that

(a)  they should not be consumed by children under 3 years of age;

(b)  they should not be used if other foods containing added 3-Fucosyllactose are consumed on the same day.

 

Authorised on 25.1.2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: ‘Chr. Hansen A/S’, Bøge Allé 10-12, 2970 Hørsholm, Denmark. During the period of data protection, the novel food 3-Fucosyllactose is authorised for placing on the market within the Union only by Chr. Hansen A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Chr. Hansen A/S’.

End date of the data protection: 25.1.2028.

Infant formula as defined under Regulation (EU) No 609/2013

0,90 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

1,20 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based foods for infants and young children and baby foods for infants and young children as defined under Regulation (EU) No 609/2013

1,20 g/l or 1,20 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Milk based drinks and similar products intended for young children

1,20 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Foods for special medical purposes for infants and young children as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than 0,9 g/l or 0,9 g/kg (if it is intended for infants from 0 until 6 months) and 1,2 g/l or 1,2 g/kg (if it is intended for infants of 6-12 months and/or for young children) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer.

Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food Supplements as defined in Directive 2002/46/EC, for the general population, excluding infants and young children

3 g/day

▼M125

3-Fucosyllactose (‘3-FL’)

(produced by derivative strain of E. coli K-12 DH1)

Specified food category

Maximum levels

(expressed as 3-Fucosyllactose)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘3-Fucosyllactose’.

The labelling of food supplements containing 3-Fucosyllactose (3-FL) shall bear a statement that

(a)  they should not be consumed by children under 3 years of age;

(b)  they should not be used if other foods containing added 3-Fucosyllactose are consumed on the same day.

 

Authorised on 12 November 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: ‘Glycom A/S’, Kogle Allé 4, 2970 Hørsholm, Denmark. During the period of data protection, the novel food 3-Fucosyllactose produced by derivative strain of E. coli K-12 DH1 is authorised for placing on the market within the Union only by Glycom A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Glycom A/S’.

End date of the data protection: 12 November 2028.

Infant formula as defined under Regulation (EU) No 609/2013

1,75 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

1,75 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products

2,0 g/L

Unflavoured fermented milk-based products

2,0 g/L (beverages)

4,0 g/kg (products other than beverages)

Flavoured fermented milk-based products including heat-treated products

2,0 g/L (beverages)

12,0 g/kg (products other than beverages)

Cereal bars

25,0 g/kg

Milk based drinks and similar products

2,0 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

12,0 g/kg (products other than beverages)

Beverages (flavoured drinks, excluding drinks with a pH less than 5)

1,25 g/L

Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013

2,0 g/L (beverages)

25,0 g/kg (products other than beverages)

Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children

In accordance with the particular nutritional requirements of the persons for whom the products are intended but in any case not higher 4,0 g/L or 4,0 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer.

Food Supplements as defined in Directive 2002/46/EC, for the general population, excluding infants and young children

4,0 g/day

▼M95

Galacto-oligosaccharide

Specified food category

Maximum levels (expressed as ratio kg galacto-oligosaccharide/kg final food)

 

 

 

Food supplements as defined in Directive 2002/46/EC

0,333

Food supplements as defined in Directive 2002/46/EC, excluding infants and young children

0,450 (corresponding to 5,4 g galacto-oligosaccharide/serving; maximum 3 servings/day up to a maximum of 16,2 g/day)

Foods for special medical purposes as defined by Regulation (EU) No 609/2013, excluding infants and young children

In accordance with the particular nutritional requirements of the persons for whom the products are intended but not more than 0,128 (corresponding to a maximum of 8,25 g galacto-oligosaccharide/day)

Milk

0,020

Milk drinks

0,030

Meal replacement for weight control (as drinks)

0,020

Dairy analogue drinks

0,020

Yoghurt

0,033

Dairy based desserts

0,043

Frozen dairy desserts

0,043

Fruit drinks and energy drinks

0,021

Infant meal replacement drinks

0,012

Baby juice

0,025

Baby yogurt drink

0,024

Baby dessert

0,027

Baby snack

0,143

Baby cereals

0,027

Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen

0,013

Juice

0,021

Fruit pie filling

0,059

Fruit preparations

0,125

Bars

0,125

Cereals

0,125

Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013

0,008

Dairy confectionery

0,05

Cheese and processed cheese

0,1

Butter and spreadable fats

0,1

▼M9

Glucosamine HCl

Specified food category

Maximum levels

 

 

 

Food Supplements as defined in Directive 2002/46/EC

In line with normal food use of glucosamine from shell fish

Foods covered by Regulation (EU) No 609/2013

 

Meal replacement for weight control

Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen

Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014

Glucosamine sulphate KCl

Specified food category

Maximum levels

 

 

 

Food Supplements as defined in Directive 2002/46/EC

In line with normal food use of glucosamine from shell fish

Glucosamine sulphate NaCl

Specified food category

Maximum levels

 

 

 

Food Supplements as defined in Directive 2002/46/EC

In line with normal food use of glucosamine from shell fish

Guar Gum

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Guar Gum’.

2.  A specific mention of the possible risks of digestive discomfort linked to the exposure of children aged under 8 to guar gum must be visible on the label of any foodstuffs containing it.

For example, ‘Excessive consumption of these products may cause digestive discomfort, especially for children under 8 years of age’.

3.  In the case of products with two compartments containing dairy and cereal products respectively, the instructions for use must clearly specify the need to mix the cereal and the dairy product before consumption, in order to take into account the potential risk of gastro-intestinal obstruction.

 

 

Fresh dairy products such as yogurts, fermented milks, fresh cheeses and other dairy-based desserts.

1,5 g/100 g

Fruit or vegetable-based liquid foodstuffs (of the ‘smoothie’ variety)

1,8 g/100 g

Fruit or vegetable-based compotes

3,25 g/100 g

Cereals accompanied by a dairy product, in packaging containing two compartments

10 g/100 g in the cereals

None in the accompanying dairy product

1 g/100 g in the product when ready to eat

Heat-treated milk products fermented with Bacteroides xylanisolvens

Specified food category

Maximum levels

 

 

 

Fermented milk products (in liquid, semi-liquid and spray-dried powder forms)

 

Hydroxytyrosol

Specified food category

Maximum levels

The designation of the novel food on the labelling of the food products containing it shall be ‘hydroxytyrosol’.

The labelling of the food products containing hydroxytyrosol shall bear the following statements:

(a)  This food product should not be consumed by children under the age of three years, pregnant women, and lactating women;

(b)  This food product should not be used for cooking, baking or frying’

 

 

Fish and vegetable oils, (except olive oils and olive pomace oils as defined in Part VIII of Annex VII of Regulation (EU) No 1308/2013 (6)), placed as such on the market

0,215 g/kg

Spreadable fats as defined in Part VII of Annex VII of Regulation (EU) No 1308/2013, placed as such on the market

0,175 g/kg

Ice Structuring Protein type III HPLC 12

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Ice Structuring Protein’

 

 

Edible ices

0,01 %

Aqueous extracts of dried leaves of Ilex guayusa

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Extracts of dried leaves of Ilex guayusa

 

 

Herbal infusions

In line with normal use in herbal infusions and food supplements of a similar aqueous extract of dried leaves of Ilex paraguariensis

Food Supplements as defined in Directive 2002/46/EC

▼M111

Infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner

(Traditional food from a third country)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Infusion from coffee leaves’ or ‘Dried infusion from coffee leaves’, depending on the form to be marketed.

 

 

Infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner placed on the market as such

 

Flavoured and unflavoured non-alcoholic ready-to-drink beverages (14)

 

Coffee, coffee and chicory extracts, instant coffee, tea, herbal- and fruit-infusions, coffee substitutes, coffee mixes and instant mixes for beverages (and their flavoured counterparts) (14)

 

▼M94

Iron hydroxide adipate tartrate

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘iron hydroxide adipate tartrate (nano)’.

The labelling of food supplements containing iron hydroxide adipate tartrate shall bear a statement that they should not be consumed by children and adolescents under the age of 18/children under 4 years of age (*)

(*)  Depending on the age group the food supplement is intended for.

 

Authorised on 28.8.2022. This inclusion is based on proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Nemysis Limited, Suite 4.01 Ormond Building 31-36 Ormond Quay Upper Arran Quay Dublin 7, D07 F6DC, Dublin, Ireland. During the period of data protection, the novel food iron hydroxide adipate tartrate is authorised for placing on the market within the Union only by Nemysis Limited, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Nemysis Limited.

End date of the data protection: 28.8.2027.

Food supplements as defined in Directive 2002/46/EC for the adult population

≤ 100 mg/day (≤ 30 mg Fe/day)

Food supplements as defined in Directive 2002/46/EC for children and adolescents under 18 years of age, excluding children under 4 years of age

≤ 50 mg/day (≤ 14 mg Fe/day)

▼M116

Iron milk caseinate

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘iron milk caseinate’.

The labelling of food supplements containing iron milk caseinate shall bear a statement that

(a)  they should not be consumed by children under 3 years of age;

(b)  they should not be consumed if other foods containing iron milk caseinate and/or if other foods with added iron are consumed the same day.

 

Authorised on 4 June 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: ‘Société des Produits Nestlé S.A.’, Avenue Nestlé 55, 1800 Vevey, Switzerland. During the period of data protection, the iron milk caseinate is authorised for placing on the market within the Union only by ‘Société des Produits Nestlé S.A.’ unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Société des Produits Nestlé S.A.’.

End date of the data protection: 4 June 2028.

Milk and dairy powder products

500 mg/100 g (≤ 10 mg Fe/100 g)

Soft-drinks marketed in relation to physical exercise

85 mg/100 g (≤ 1,7 mg Fe/100 g)

Powder cocoa beverage preparations

400 mg/100 g (≤ 8 mg Fe/100 g)

Powder or liquid malt-based coffee substitutes

1 050 mg/100 g (≤ 21 mg Fe/100 g)

Cereal bars

350 mg/100 g (≤ 7 mg Fe/100 g)

 

 

Noodles other than glass noodles

75 mg/100 g (≤ 1,5 mg Fe/100 g)

Stock cubes or granulates (bouillon base)

4 750 mg/100 g (≤ 95 mg Fe/100 g)

Single meal replacements for weight control

120 mg/100 g (≤ 2,4 mg Fe/100 g)

Total diet replacement for weight control as defined under Regulation (EU) No 609/2013

235 mg/meal (≤ 4,7 mg Fe/meal) or 700 mg/day (≤ 14,0 mg/Fe/day)

Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food supplements as defined in Directive 2002/46/EC, for the adult population

700 mg/day (≤ 14 mg Fe/day)

Food supplements as defined in Directive 2002/46/EC, for children and adolescents under 18 years of age, excluding infants and young children

350 mg/day (≤ 7 mg Fe/day)

▼M9

Isomalto-oligosaccharide

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Isomaltooligosaccharide’.

2.  Foods containing the novel ingredient must be labelled as ‘a source of glucose’.

 

 

Energy-Reduced Soft Drinks

6,5 %

Energy Drinks

5,0 %

Foods intended to meet the expenditure of intense muscular efforts, especially for sportsmen (including isotonic drinks)

6,5 %

Fruit Juices

5 %

Processed Vegetables and Vegetable Juices

5 %

Other Soft Drinks

5 %

Cereals Bars

10 %

Cookies, Biscuits

20 %

Breakfast Cereal Bars

25 %

Hard Candies

97 %

Soft Candies/Chocolate Bars

25 %

Meal replacement for weight control (as bars or milk based)

20 %

Isomaltulose

Not specified

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Isomaltulose’.

2.  The designation of the novel food on the labelling shall be accompanied by indication that the ‘Isomaltulose is a source of glucose and fructose’.

 

 

▼M90

Jatropha curcas L. (edible variety) kernels

Specified food category

Maximum levels (g/100g)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘kernels from edible Jatropha curcas L.’

 

Authorised on 12 July 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: ‘JatroSolutions GmbH’, Echterdinger Strasse 30, 70599 Stuttgart, Germany. During the period of data protection, the novel food kernels from the edible variety of Jatropha curcas L. is authorised for placing on the market within the Union only by ‘JatroSolutions GmbH’, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘JatroSolutions GmbH’.

End date of the data protection: 12 July 2027.

Kernels as such, candied or sugar preserved and as processed nuts

 

Cereal bars

5

Breakfast cereals

5

Dried fruits

5

 

▼M130

Lactitol

Specified food category

Maximum levels

The designation of the novel food on the labelling of the food supplements containing it shall be ‘Lactitol’

 

 

Food supplements as defined in Directive 2002/46/EC intended for the adult population

20 g/day

▼M119

Lacto-N-neotetraose

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘lacto-N-neotetraose’.

2.  The labelling of food supplements containing lacto-N-neotetraose shall bear a statement that the supplements should not be used if other foods with added lacto-N-neotetraose are consumed the same day.

3.  The labelling of food supplements containing lacto-N-neotetraose intended for young children shall bear a statement that the supplements should not be used if breast milk or other foods with added lacto-N-neotetraose are consumed the same day.

 

 

Unflavoured pasteurised and sterilised (including UHT) milk-based products

0,6 g/l

Unflavoured fermented milk-based products

0,6 g/l for beverages

9,6 g/kg for products other than beverages

Flavoured fermented milk-based products including heat-treated products

0,6 g/l for beverages

9,6 g/kg for products other than beverages

Dairy analogues, including beverage whiteners

0,6 g/l for beverages

6 g/kg for products other than beverages

200 g/kg for whitener

Cereal bars

6 g/kg

Table-top sweeteners

100 g/kg

Infant formula as defined under Regulation (EU) No 609/2013

0,6 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

0,6 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based foods and baby foods for infants and young children as defined under Regulation (EU) No 609/2013

6 g/kg for products other than beverages

0,6 g/l for liquid food ready for use, marketed as such or reconstituted as instructed by the manufacturer

Milk based drinks and similar products intended for young children

0,6 g/l for milk-based drinks and similar products in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Foods for special medical purposes as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013

2,4 g/l for drinks

20 g/kg for bars

Bread and pasta products bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014

30 g/kg

Flavoured drinks

0,6 g/l

Coffee, tea (excluding black tea), herbal and fruit infusions, chicory; tea, herbal and fruit infusions and chicory extracts; tea, plant, fruit and cereal preparations for infusions, as well as mixes and instant mixes of these products

4,8 g/l – the maximum level refers to the products ready to use

Food Supplements as defined in Directive 2002/46/EC, for the general population, excluding infants

1,5 g/day for general population

0,6 g/day for young children

▼M45

Lacto-N-tetraose (‘LNT’)

(microbial source)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘lacto-N-tetraose’.

The labelling of food supplements containing lacto-N-tetraose shall bear a statement that they should not be used if breast milk or other foods containing added lacto-N-tetraose are consumed the same day.

 

Authorised on 23.4.2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food lacto-N-tetraose is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S.

End date of the data protection: 23.4.2025.

Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products

1,0 g/l

Unflavoured fermented milk-based products

1,0 g/l (beverages)

10 g/kg (products other than beverages)

Flavoured fermented milk-based products including heat-treated products

1,0 g/l (beverages)

10 g/kg (products other than beverages)

Beverages (flavoured drinks)

1,0 g/l

Cereal bars

10 g/kg

Infant formula as defined under Regulation (EU) No 609/2013

0,8 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

0,6 g/l in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based food, baby food for infants and young children as defined under Regulation (EU) No 609/2013

0,6 g/l (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

5 g/kg for products other than beverages

Milk based drinks and similar products intended for young children

0,6 g/l (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

5 g/kg for products other than beverages

Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013

2,0 g/l (beverages)

20 g/kg (products other than beverages)

Food for special medical purposes as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food Supplements as defined in Directive 2002/46/EC, excluding infants

2,0 g/day for young children, children, adolescents, and adults

▼M101

Lacto-N-tetraose (‘LNT’)

(produced by derivative strains of E. coli BL21(DE3))

Specified food category

Maximum levels (expressed as lacto-N-tetraose)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘lacto-N-tetraose’.

The labelling of food supplements containing lacto-N-tetraose (LNT) shall bear a statement that

(a)  they should not be consumed by children under 3 years of age;

(b)  they should not be used if other foods containing added lacto-N-tetraose are consumed the same day.

 

Authorised on 24.1.2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: ‘Chr. Hansen A/S’, Boege Allé 10-12, 2970 Hoersholm, Denmark. During the period of data protection, the novel food Lacto-N-tetraose is authorised for placing on the market within the Union only by ‘Chr. Hansen A/S’ unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Chr. Hansen A/S’.

End date of the data protection: 24.1.2028.

Infant formula as defined under Regulation (EU) No 609/2013

1,82 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

1,82 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based foods and baby foods for infants and young children as defined under Regulation (EU) No 609/2013

1,82 g/L or 1,82 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Milk based drinks and similar products intended for young children

1,82 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Foods for special medical purposes for infants and young children as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than 1,82 g/L or 1,82 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer.

Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food supplements as defined in Directive 2002/46/EC, for the general population, excluding infants and young children

4,6 g/day

▼M21

Lonicera caerulea L. berries (haskap)

(Traditional food from a third country)

Not specified

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘haskap (Lonicera caerulea) berries’

 

 

▼M9

Lucerne leaf extract from Medicago sativa

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lucerne (Medicago sativa) protein’ or ‘Alfalfa (Medicago sativa) protein’.

 

 

Food supplements as defined in Directive 2002/46/EC

10 g/day

Lycopene

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lycopene’

 

 

Fruit/vegetable juice-based drinks (including concentrates)

2,5 mg/100 g

Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen

2,5 mg/100 g

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

8 mg/meal

Breakfast cereals

5 mg/100 g

Fats and dressings

10 mg/100 g

Soups other than tomato soups

1 mg/100 g

Bread (including crispy breads)

3 mg/100 g

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food supplements as defined in Directive 2002/46/EC

15 mg/day

Lycopene from Blakeslea trispora

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lycopene’

 

 

Fruit/vegetable juice-based drinks (including concentrates)

2,5 mg/100 g

Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen

2,5 mg/100 g

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

8 mg/meal

Breakfast cereals

5 mg/100 g

Fats and dressings

10 mg/100 g

Soups other than tomato soups

1 mg/100 g

Bread (including crispy breads)

3 mg/100 g

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food supplements as defined in Directive 2002/46/EC

15 mg/day

Lycopene from tomatoes

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lycopene’

 

 

Fruit/vegetable juice-based drinks (including concentrates)

2,5 mg/100 g

Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen

2,5 mg/100 g

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

8 mg/meal

Breakfast cereals

5 mg/100 g

Fats and dressings

10 mg/100 g

Soups other than tomato soups

1 mg/100 g

Bread (including crispy breads)

3 mg/100 g

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food supplements as defined in Directive 2002/46/EC

15 mg/day

Lycopene oleoresin from tomatoes

Specified food category

Maximum levels of lycopene

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Lycopene oleoresin from tomatoes’

 

 

Fruit/vegetable juice-based drinks (including concentrates)

2,5 mg/100 g

Drinks intended to meet the expenditure of intense muscular effort especially for sportsmen

2,5 mg/100 g

Total diet replacement for weight control covered by Regulation (EU) No 609/2013 and meal replacements for weight control

8 mg/meal

Breakfast cereals

5 mg/100 g

Fats and dressings

10 mg/100 g

Soups other than tomato soups

1 mg/100 g

Bread (including crispy breads)

3 mg/100 g

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

▼M52

Hen egg white lysozyme hydrolysate

Specified food category

Maximum levels

The designation of the novel food on the labelling of food supplements containing it shall be ‘Hen egg white lysozyme hydrolysate’.

 

 

Food supplements as defined in Directive 2002/46/EC intended for adult population

1000 mg/day

▼M9

Magnesium citrate malate

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Magnesium citrate malate’

 

 

Food Supplements as defined in Directive 2002/46/EC

 

Magnolia Bark Extract

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Magnolia Bark Extract’

 

 

Mints (confectionary products)

0,2 % for breath freshening purposes. Based on a 0,2 % maximum incorporation level and a maximum gum/mint size of 1,5 g each, each gum or mint serving will contain no more than 3 mg of magnolia bark extract.

Chewing gum

Maize-germ oil high in unsaponifiable matter

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Maize-germ oil extract’

 

 

Food Supplements as defined in Directive 2002/46/EC

2 g/day

Chewing gum

2 %

Methylcellulose

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Methylcellulose’

Methylcellulose is not to be used in foods specially prepared for young children

 

Edible ices

2 %

Flavoured drinks

Flavoured or unflavoured fermented milk products

Cold desserts (dairy, fat, fruit, cereal, egg-based products)

Fruit preparations (pulps, purees or compotes)

Soups and broths

▼M11

1-Methylnicotinamide chloride

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘1- Methylnicotinamide chloride’.

Food supplements containing 1-Methylnicotinamide shall bear the following statement:

This food supplement should be consumed by adults only excluding pregnant and lactating women

 

Authorised on 2 September 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Pharmena SA, Wolczanska 178, 90 530 Lodz, Poland. During the period of data protection the novel food 1-methylnicotinamide chloride is authorised for placing on the market within the Union only by Pharmena S.A. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Pharmena S.A.

End date of the data protection: 2 September 2023

Food Supplements as defined in Directive 2002/46/EC for the adult population excluding pregnant and lactating women

58 mg/day

▼M9

(6S)-5-methyltetrahydrofolic acid, glucosamine salt

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘(6S)-5-methyltetrahydrofolic acid, glucosamine salt’ or ‘5MTHF-glucosamine’

 

 

Food Supplements as defined in Directive 2002/46/EC as a source of folate

 

 

 

 

Monomethylsilanetriol (Organic Silicon)

Specified food category

Maximum levels of silicon

The designation of the novel food on the labelling of the food supplements containing it shall be ‘Organic silicon (monomethylsilanetriol)’

 

 

Food Supplements as defined in Directive 2002/46/EC for adult population (in liquid form)

10,40 mg/day

▼M133

Monosodium salt of L-5-methyltetrahydrofolic acid

Specified food category

Maximum levels

(expressed as folic acid)

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Monosodium salt of L-5-methyltetrahydrofolic acid (folic acid)’.

2.  The labelling of food supplements containing monosodium salt of L-5-methyltetrahydrofolic acid shall bear a statement that the food supplements should not be consumed by infants and young children (children under 3 years of age)

 

Authorised on 30 April 2024. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Merck & Cie KmG, Im Laternenacker 5, 8200 Schaffhausen, Switzerland. During the period of data protection, the novel food monosodium salt of L-5-methyltetrahydrofolic acid is authorised for placing on the market within the Union only by Merck & Cie KmG, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Merck & Cie KmG.

End date of the date protection: 30 April 2029.

Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

In accordance with Directive 2002/46/EC

Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Processed cereal-based foods and baby foods for infants and young children as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Food fortified in accordance with Regulation (EC) No 1925/2006

In accordance with Regulation (EC) No 1925/2006

▼M87

Mung bean (Vigna radiata) protein

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘mung bean protein from Vigna radiata’.

 

Authorised on 15 May 2022. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Eat Just, Inc., 2000 Folsom Street San Francisco, CA 94110 USA. During the period of data protection, the novel mung bean protein is authorised for placing on the market within the Union only by Eat Just, Inc., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Eat Just, Inc.

End date of the date protection: 15 May 2027.

Protein products

20 g/100 g

▼M9

Mycelial extract from Shiitake mushroom (Lentinula edodes)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘extract from the mushroom Lentinula edodes’ or ‘extract from Shiitake mushroom’

 

 

Bread products

2 ml/100 g

Soft drinks

0,5 ml/100 ml

Ready prepared meals

2,5 ml per meal

Foods based on yoghurt

1,5 ml/100 ml

Food supplements as defined in Directive 2002/46/EC

2,5 ml per day dose

▼M92

Nicotinamide riboside chloride

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘nicotinamide riboside chloride’.

 

Authorised on 20 February 2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: ChromaDex Inc., 10900 Wilshire Boulevard Suite 600, Los Angeles, CA 90024 USA. During the period of data protection, the novel food is authorised for placing on the market within the Union only by ChromaDex Inc. unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ChromaDex Inc.

End date of the data protection: 20 February 2025.

Food supplements as defined in Directive 2002/46/EC

300 mg/day for the adult population, excluding pregnant and lactating women

230 mg/day for pregnant and lactating women

Foods for special medical purposes as defined by Regulation (EU) No 609/2013 for the adult population, excluding pregnant and lactating women

In accordance with the particular nutritional requirements of the persons for whom the products are intended

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘nicotinamide riboside chloride’

2.  The labelling of foodstuffs containing the novel food shall bear a statement that those foods should only be consumed by persons above 18 years of age excluding pregnant and lactating women.

 

 

Total diet replacement for weight control as defined by Regulation (EU) No 609/2013 for the adult population, excluding pregnant and lactating women

500 mg/day

Meal replacements for the adult population, excluding pregnant and lactating women

150 mg/meal (maximum 2 meals/day up to a maximum of 300 mg/day)

▼M9

Noni fruit juice (Morinda citrifolia)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Noni juice’ or ‘Juice of Morinda citrifolia

 

 

Pasteurised fruit and fruit nectar based drinks

30 ml with one serving (up to 100 % noni juice)

or

20 ml twice a day, not more than 40 ml per day

Noni fruit juice powder (Morinda citrifolia)

Food supplements as defined in Directive 2002/46/EC

6,6 g/day (equivalent to 30 ml of noni juice)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Noni juice powder’ or ‘Juice powder of Morinda citrifolia

 

 

Noni fruit puree and concentrate (Morinda citrifolia)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be:

For fruit puree:

Morinda citrifolia fruit puree’ or ‘Noni fruit puree’

For fruit concentrate:

Morinda citrifolia fruit concentrate’ or ‘Noni fruit concentrate’

 

 

 

Fruit puree

Candy/confectionery

45 g/100 g

Cereal bars

53 g/100 g

Powdered nutritional drink mixes (dry weight)

53 g/100 g

Carbonated beverages

11 g/100 g

Ice cream & sorbet

31 g/100 g

Yoghurt

12 g/100 g

Biscuits

53 g/100 g

Buns, cakes and pastries

53 g/100 g

Breakfast cereals (wholegrain)

88 g/100 g

Jams and jellies in accordance with Directive 2001/113/EC

133 g/100 g

Based on pre-processing quantity to produce final 100 g product

Sweet spreads, fillings and icings

31 g/100 g

Savoury sauces, pickles, gravies and condiments

88 g/100 g

Food Supplements as defined in Directive 2002/46/EC

26 g/day

 

Fruit concentrate

Candy/Confectionery

10 g/100 g

Cereal bars

12 g/100 g

Powdered nutritional drink mixes (dry weight)

12 g/100 g

Carbonated beverages

3 g/100 g

Ice cream & sorbet

7 g/100 g

Yoghurt

3 g/100 g

Biscuits

12 g/100 g

Buns, cakes and pastries

12 g/100 g

Breakfast cereals (wholegrain)

20 g/100 g

Jams and jellies in accordance with Directive 2001/113/EC

30 g/100 g

Sweet spreads, fillings and icings

7 g/100 g

Savoury sauces, pickles, gravies and condiments

20 g/100 g

Food Supplements as defined in Directive 2002/46/EC

6 g/day

Noni leaves (Morinda citrifolia)

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Noni leaves’ or ‘leaves of Morinda citrifolia’.

2.  Instructions shall be given to the consumer that a cup of infusion should not be prepared with more than 1 g of dried and roasted leaves of Morinda citrifolia.

 

 

For the preparation of infusions

A cup of infusion to be consumed shall not be prepared with more than 1 g of dried and roasted leaves of Morinda citrifolia

Noni fruit powder (Morinda citrifolia)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Morinda citrifolia fruit powder’ or ‘Noni fruit powder’

 

 

Food Supplements as defined in Directive 2002/46/EC

2,4 g per/day

Odontella aurita microalgae

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Odontella aurita microalgae’

 

 

Flavoured pasta

1,5 %

Fish soups

1 %

Marine terrines

0,5 %

Broth preparations

1 %

Crackers

1,5 %

Frozen breaded fish

1,5 %

Oil enriched with phytosterols/phytostanols

Specified food category

Maximum levels of phytosterols/ phytostanols

In accordance with Annex III.5 to Regulation (EU) No 1169/2011

 

 

Spreadable fats as defined in Annex VII, Part VII and Appendix II, points B and C of Regulation (EU) No 1308/2013, and excluding cooking and frying fats and spreads based on butter or other animal fat

1.  The products containing the novel food ingredient shall be presented in such a manner that they can be easily divided into portions that contain either a maximum of 3 g (in case of one portion per day) or a maximum of 1 g (in case of three portions per day) of added phytosterols/phytostanols.

2.  The amount of phytosterols/phytostanols added to a container of beverages shall not exceed 3 g.

3.  Salad dressings, mayonnaise and spicy sauces shall be packed as single portions.

Milk based products, such as products based on semi-skimmed and skimmed milk products, possibly with the addition of fruits and/or cereals, products based on fermented milk such as yoghurt and cheese based products (fat content ≤ 12 g per 100 g), where possibly the milk fat has been reduced and the fat or protein has been partly or fully replaced by vegetable fat or protein

Soya drinks

Salad dressings, mayonnaise and spicy sauces

Oil extracted from squids

Specified food category

Maximum levels of DHA and EPA combined

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Squid oil’.

 

 

Dairy products except milk-based beverages

200 mg/100 g or for cheese products 600 mg/100 g

Dairy analogues except drinks

200 mg/100 g or for analogues to cheese products 600 mg/100 g

Spreadable fat and dressings

600 mg/100 g

Breakfast cereals

500 mg/100 g

Bakery products (breads and bread rolls)

200 mg/100 g

Cereal bars

500 mg/100 g

Non-alcoholic beverages (including milk-based beverages)

60 mg/100 ml

Food Supplements as defined in Directive 2002/46/EC

3 000 mg/day for general population

450 mg/day for pregnant and lactating women

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products intended

Total diet replacement for weight control defined in Regulation (EU) No 609/2013 and meal replacements for weight control

200 mg/meal

▼M55

Extract from Panax notoginseng and Astragalus membranaceus

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Extract from Panax notoginseng and Astragalus membranaceus

The labelling of food supplements containing extract from Panax notoginseng and Astragalus membranaceus shall bear a statement that those food supplements should not be consumed by the population under 18 years of age and by pregnant women.

 

Authorised on 23 December 2020. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: NuLiv Science, 1050 W. Central Ave., Building C, Brea, CA 92821, USA.

During the period of data protection, the novel food is authorised for placing on the market within the Union only by NuLiv Science, unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of NuLiv Science.

End date of the data protection: 23 December 2025.

Food supplements as defined in Directive 2002/46/EC for the general adult population, excluding food supplements for pregnant women

35 mg/day

▼M126

Partially defatted chia seed (Salvia hispanica L.) powders

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Partially defatted chia seed (Salvia hispanica) powder’

 

 

Powder with high protein content

Unflavoured fermented milk products, including natural unflavoured buttermilk (excluding sterilised buttermilk) non-heat-treated after fermentation

0,7 %

Unflavoured fermented milk products, heat-treated after fermentation

0,7 %

Flavoured fermented milk products including heat-treated products

0,7 %

Confectionery

10 %

Fruit juices as defined by Council Directive 2001/112/EC (8) and vegetable juices

2,5 %

Fruit nectars as defined by Directive 2001/112/EC and vegetable nectars and similar products

2,5 %

Flavoured drinks

3 %

Food supplements as defined in Directive 2002/46/EC excluding food supplements for infants and young children

7,5 g/day

Powder with high fibre content

Authorised for use in cakes and pastries, processed fruit and vegetables (including vegetable-based dishes), bread and rolls, pasta based products and protein products on 13 November 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Functional Products Trading Arica S.A./BENEXIA, Luis Pasteur 5850, Oficina 403, Quinto Piso. Vitacura, Santiago – Chile. During the period of data protection, partially defatted chia seed (Salvia hispanica L.) powder with a high fibre content for use in cakes and pastries, processed fruit and vegetables (including vegetable-based dishes), bread and rolls, pasta based products and protein products is authorised for placing on the market within the Union only by Functional Products Trading Arica S.A./BENEXIA, unless a subsequent applicant obtains authorisation for the same novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Functional Products Trading Arica S.A./BENEXIA.

End date of the data protection: 13 November 2028.

Confectionery

4 %

Fruit juices as defined by Directive 2001/112/EC and vegetable juices

2,5 %

Fruit nectars as defined by Directive 2001/112/EC and vegetable nectars and similar products

4 %

Flavoured drinks

4 %

Food supplements as defined in Directive 2002/46/EC excluding food supplements for infants and young children

12 g/day

Cakes and pastries

5 g/100 g

Processed fruit and vegetables (including vegetable-based dishes)

10 g/100 g

Bread and rolls

10 g/100 g

Pasta based products

8 g/100 g

Protein products

10 g/100 g

▼M63

Partially defatted rapeseed powder from Brassica rapa L. and

Brassica napus L.

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Partially defatted Rapeseed powder’.

Any foodstuff containing ‘Partially defatted Rapeseed powder’ from Brassica rapa L. and Brassica napus L.’ shall bear a statement that this ingredient may cause allergic reaction to consumers who are allergic to mustard and products thereof. That statement shall appear in close proximity to the list of ingredients.

 

 

Cereal bars mixed

20 g/100 g

Muesli and similar breakfast cereals

20 g/100 g

Extruded breakfast cereal products

20 g/100 g

Snacks (excluding potato crisps)

15 g/100 g

Breads and rolls with added special ingredients (such as seeds, raisins, herbs)

7 g/100 g

Brown breads bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014

7 g/100 g

Multigrain bread and rolls

7 g/100 g

Meat substitutes

10 g/100 g

Meat balls

10 g/100 g

▼M9

Pasteurised fruit-based preparations produced using high-pressure treatment

Specified food category

Maximum levels

The wording ‘pasteurised by high-pressure treatment’ shall be displayed next to the name of the fruit preparations as such and in any product in which it is used

 

 

Types of fruit:

apple, apricot, banana, blackberry, blueberry, cherry, coconut, fig, grape, grapefruit, mandarin, mango, melon, peach, pear, pineapple, prune, raspberry, rhubarb, strawberry

 

▼M100

Pea and rice protein fermented by Lentinula edodes (Shiitake mushroom) mycelia

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Pea and rice protein fermented by Shiitake mushroom mycelia’.

 

Authorised on 24.1.2023. This inclusion is based on proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: MycoTechnology, Inc., 18250 E. 40th Avenue, Suite 50, Aurora, 80011 Colorado, United States. During the period of data protection, the novel food pea and rice protein fermented by Lentinula edodes (Shiitake mushroom) mycelia is authorised for placing on the market within the Union only by MycoTechnology, Inc. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of MycoTechnology, Inc.

End date of the data protection: 24.1.2028.

Bakery wares, breads, rolls, croutons, pizza

5 g/100 g

Breakfast cereals and cereal bars

33 g/100 g

Fruit- and vegetable-based drinks

20 g/100 ml

Ready-to-mix beverage powders

93 g/100 g

Cocoa and chocolate confectionary

7 g/100 g

Dairy analogues and non-dairy meal replacements for weight control

11 g/100 g

Fermented milk-based products

5 g/100 g

Pasta-based products

15 g/100 g

Meat preparations and meat products

14 g/100 g

Soups (ready-to-eat) and soup concentrates or powders

3 g/100 g

Salads

26 g/100 g

Meat analogues

40 g/100 g

Milk-based drinks

1 g/100 g

Single meal replacements for weight control

1 g/100 g

▼M37

Phenylcapsaicin

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘phenylcapsaicin’.

 

Authorised on 19 December 2019. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: aXichem AB, Södergatan 26, SE 211 34, Malmö Sweden. During the period of data protection, the novel food phenylcapsaicin is authorised for placing on the market within the Union only by aXichem AB, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of aXichem AB.

Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants, young children and children under the age of 11 years

2,5 mg/day

Food supplements as defined in Directive 2002/46/EC intended for the general population, excluding children under the age of 11 years

2,5 mg/day

▼M9

Phosphated maize starch

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Phosphated maize starch’

 

 

Baked bakery products

15 %

Pasta

Breakfast cereals

Cereal bars

▼M112

Phosphated wheat starch

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Phosphated wheat starch’.

 

 

Baked bakery products

15  %

Pasta

Breakfast cereals

Cereal bars

▼M9

Phosphatidylserine from fish phospholipids

Specified food category

Maximum levels of phosphatidylserine

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Fish phosphatidylserine’

 

 

Beverages based on yoghurt

50 mg/100 ml

Powders based on milk powders

3 500 mg/100 g (equivalent to 40 mg/100 ml ready to drink)

Foods based on yoghurt

80 mg/100 g

Cereal bars

350 mg/100 g

Chocolate based confectionary

200 mg/100 g

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In compliance with Regulation (EU) No 609/2013

Food supplements as defined in Directive 2002/46/EC

300 mg/day

Phosphatidylserine from soya phospholipids

Specified food category

Maximum levels of phosphatidylserine

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Soya phosphatidylserine’

 

 

Beverages based on yoghurt

50 mg/100 ml

Powders based on milk powder

3,5 g/100 g (equivalent to 40 mg/100 ml ready to drink)

Foods based on yoghurt

80 mg/100 g

Cereal bars

350 mg/100 g

Chocolate based confectionary

200 mg/100 g

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In compliance with Regulation (EU) No 609/2013

Phospholipid product containing equal amounts of phosphatidylserine and phosphatidic acid

Specified food category

Maximum levels of phosphatidylserine

The designation of the novel food on the labelling of the foodstuffs containing shall be ‘Soy phosphatidylserine and phosphatidic acid’

The product is not intended to be marketed to pregnant or breast-feeding women

 

Breakfast cereals

80 mg/100 g

Cereal bars

350 mg/100 g

Foods based on yogurt

80 mg/100 g

Soy-based yogurt-like products

80 mg/100 g

Yogurt based-drinks

50 mg/100 g

Soy-based yogurt-like drinks

50 mg/100 g

Powders based on milk powder

3,5 g/100 g (equivalent to 40 mg/100 ml ready-to drink)

Food Supplements as defined in Directive 2002/46/EC

800 mg/day

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In compliance with Regulation (EU) No 609/2013

Phospholipides from egg yolk

Specified food category

Maximum levels

 

 

 

Not specified

Phytoglycogen

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Phytoglycogen’

 

 

Processed foods

25 %

Phytosterols/phytostanols

Specified food category

Maximum levels

In accordance with Annex III.5 of Regulation (EU) No 1169/2011

 

 

Rice drinks

1.  They shall be presented in such a manner that they can be easily divided into portions that contain either a maximum of 3 g (in case of 1 portion/day) or a maximum of 1 g (in case of 3 portions/day) of added phytosterols/phytostanols.

The amount of phytosterols/phytostanols added to a container of beverages shall not exceed 3 g.

Salad dressings, mayonnaise and spicy sauces shall be packed as single portions

Rye bread with flour containing ≥ 50 % rye (wholemeal rye flour, whole or cracked rye kernels and rye flakes) and ≤ 30 % wheat; and with ≤ 4 % added sugar but no fat added.

Salad dressings, mayonnaise and spicy sauces.

Soya drink

Milk type products, such as semi-skimmed and skimmed milk type products, possibly with the addition of fruits and/or cereals, where possibly the milk fat has been reduced, or where milk fat and/or protein has been partly or fully replaced by vegetable fat and/or protein.

Products based on fermented milk such as yoghurt and cheese type products (fat content < 12 % per 100 g), where possibly the milk fat has been reduced, or where milk fat and/or protein has been partly or fully replaced by vegetable fat and/or protein

Spreadable fats as defined in Annex VII, Part VII and Appendix II, points B and C of Regulation (EU) No 1308/2013, and excluding cooking and frying fats and spreads based on butter or other animal fat.

Food Supplements as defined in Directive 2002/46/EC

3 g/day

Plum kernel oil

Specified food category

Maximum levels

 

 

 

For frying and as seasoning

In line with normal food use of vegetable oils

Potato proteins (coagulated) and hydrolysates thereof

Not specified

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Potato protein’

 

 

Prolyl oligopeptidase (enzyme preparation)

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Prolyl oligopeptidase’

 

 

Food Supplements as defined in Directive 2002/46/EC for general adult population

120 PPU/day (2,7 g of enzyme preparation/day) (2 × 106 PPI/day)

PPU – Prolyl Peptidase Units or Proline Protease Units

PPI – Protease Picomole International

▼M136

Protein concentrate from Lemna gibba and Lemna minor

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘protein concentrate from the Lemna gibba and Lemna minor plants’ or ‘protein concentrate from the Lemna gibba plant’ depending on the presence of Lemna minor.

2.  Where foods containing the novel food include an amount of vitamin K that is considered significant in accordance with point 2 of Part A of Annex XIII to Regulation (EU) No 1169/2011, the nutrition declaration shall indicate the amount of vitamin K.

 

Authorised on 30 April 2024. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: ABC Kroos BV, Drosteweg 8, 8101 NB Raalte, NETHERLANDS. During the period of data protection, the novel food protein concentrate from Lemna gibba and Lemna minor is authorised for placing on the market within the Union only by ABC Kroos BV, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ABC Kroos BV.

End date of the date protection: 30 April 2029.

Cereal bars

10 g/100 g

Prepacked bread and rolls

1,7 g/100 g

Powdered drink mixes

20 g/100 g

Noodles

6 g/100 g

Food supplements as defined in Directive 2002/46/EC for the adult population

1 g/day

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘protein concentrate from the Lemna gibba and Lemna minor plants’ or ‘protein concentrate from Lemna gibba plant’ depending on the presence of Lemna minor.

2.  The labelling of food supplements containing the novel food shall bear a statement that they should only be consumed by adults.

3.  Where food supplements containing the novel food include an amount of vitamin K that is considered significant in accordance with point 2 of Part A of Annex XIII to Regulation (EU) No 1169/2011 and Article 8 of Directive 2002/46/EC, the labelling of food supplements containing novel food shall indicate the amount of vitamin K.

▼M50

Protein extract from pig kidneys

Specified food category

Maximum levels

 

 

 

Food Supplements as defined in Directive 2002/46/EC

3 capsules or 3 tablets/day; equalising 12,6 mg pig kidney extract a day Diamine oxidase (DAO) content: 0,9 mg/day (3 capsules or 3 tablets with a content of DAO of 0,3 mg/capsule or 0,3 mg/tablet)

Food for special medical purposes as defined in Regulation (EU) No 609/2013

▼M10

Pyrroloquinoline quinone disodium salt

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Pyrroloquinoline quinone disodium salt’.

Food supplements containing Pyrroloquinoline quinone disodium salt shall bear the following statement:

This food supplement should be consumed by adults only excluding pregnant and lactating women

 

Authorised on 2 September 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Mitsubishi Gas Chemical Company, Inc., Mitsubishi Building 5-2 Marunouchi 2-chome, Chiyoda-ku, Tokyo 100-8324, Japan. During the period of data protection the novel food Pyrroloquinoline quinone disodium salt is authorised for placing on the market within the Union only by Mitsubishi Gas Chemical Company, Inc., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Mitsubishi Gas Chemical Company, Inc.

End date of the data protection: 2 september 2023

Food Supplements as defined in Directive 2002/46/EC intended for the adult population, excluding pregnant and lactating women

20 mg/day

▼M9

Rapeseed oil high in unsaponifiable matter

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Rapeseed oil extract’

 

 

Food Supplements as defined in Directive 2002/46/EC

1,5 g per portion recommended for daily consumption

Rapeseed Protein

As a vegetable protein source in foods except in infant formula and follow-on formula

 

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Rapeseed protein’.

2.  Any foodstuff containing ‘rapeseed protein’ shall bear a statement that this ingredient may cause allergic reaction to consumers who are allergic to mustard and products thereof. Where relevant, this statement shall appear in close proximity to the list of ingredients.

 

 

▼M17

Refined shrimp peptide concentrate

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘refined shrimp peptide concentrate’.

 

Authorised on 20 November 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Marealis AS., Stortorget 1, Kystens Hus, 2nd floor, N-9008 Tromsø Postal address: P.O. Box 1065, 9261 Tromsø, Norway. During the period of data protection the novel food refined shrimp peptide concentrate is authorised for placing on the market within the Union only by Marealis AS unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Marealis AS.

End date of the data protection: 20 November 2023.

Food Supplements as defined in Directive 2002/46/EC for the adult population

1 200 mg/day

▼M59

Trans-resveratrol

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the food supplements containing it shall be ‘Trans-resveratrol’.

2.  The labelling of food supplements containing trans-resveratrol shall bear a statement that people using medicines should only consume the product under medical supervision.

 

 

Food supplements as defined in Directive 2002/46/EC for the adult population

150 mg/day

▼M9

Trans-resveratrol (microbial source)

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the food supplements containing it shall be ‘Trans-resveratrol’.

2.  The labelling of food supplements containing trans-resveratrol shall bear a statement that people using medicines should only consume the product under medical supervision.

 

 

Food supplements as defined in Directive 2002/46/EC

In line with normal use in food supplements of resveratrol extracted from Japanese knotweed (Fallopia japonica)

Rooster comb extract

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Rooster comb extract’ or ‘Cockerel comb extract’

 

 

Milk-based drinks

40 mg/100 g or mg/100 ml

Milk based fermented drinks

80 mg/100 g or mg/100 ml

Yoghurt-type products

65 mg/100 g or mg/100 ml

Fromage frais

110 mg/100 g or mg/100 ml

Sacha inchi oil from Plukenetia volubilis

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Sacha inchi oil (Plukenetia volubilis)’

 

 

As for linseed oil

In line with normal food use of linseed oil

Salatrims

Specified food category

Maximum levels

1.  The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘reduced energy fat (salatrims)’.

2.  There shall be a statement that excessive consumption may lead to gastro-intestinal disturbance.

3.  There shall be a statement that the products are not intended for use by children.

 

 

Bakery products and confectionary

 

▼M93

Schizochytrium sp. oil rich in DHA and EPA

Specified food category

Maximum levels of DHA and EPA combined

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘DHA and EPA-rich oil from the microalgae Schizochytrium sp.’

 

 

Food supplements as defined in Directive 2002/46/EC for the adult population excluding pregnant and lactating women

3 000 mg/day

Food supplements as defined in Directive 2002/46/EC for pregnant and lactating women

450 mg/day

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

250 mg/meal

Milk-based drinks and similar products intended for young children

200 mg/100 g

Processed cereal based food and baby food for infants and young children as defined in Regulation (EU) No 609/2013

Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen

Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014

Bakery products (breads, rolls and sweet biscuits)

Breakfast cereals

500 mg/100 g

Cooking fats

360 mg/100 g

Dairy analogues, except drinks

600 mg/100 g for cheese; 200 mg/100 g for soy and imitation milk products (excluding drinks)

Dairy products except milk-based drinks

600 mg/100 g for cheese; 200 mg/100 g for milk products (including milk, fromage frais and yoghurt products; excluding drinks)

Non-alcoholic beverages (including dairy analogue and milk-based drinks)

80 mg/100 g

Cereal/nutrition bars

500 mg/100 g

Spreadable fats and dressings

600 mg/100 g

Fish analogues

300 mg/100 g

Meat analogues

300 mg/100 g

▼M27

Schizochytrium sp. (ATCC PTA-9695) oil

Specified food category

Maximum levels of DHA

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the microalgae Schizochytrium sp.’

 

 

Dairy products except milk-based drinks

200 mg/100 g or for cheese products 600 mg/100 g

Dairy analogues except drinks

200 mg/100 g or for analogues to cheese products 600 mg/100 g

Spreadable fats and dressings

600 mg/100 g

Breakfast cereals

500 mg/100 g

Food Supplements as defined in Directive 2002/46/EC

250 mg DHA/day for general population

450 mg DHA/day for pregnant and lactating women

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

250 mg/meal

Milk-based drinks and similar products intended for young children

200 mg/100 g

Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen

Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Bakery products (breads, rolls, and sweet biscuits)

200 mg/100 g

Cereal bars

500 mg/100 g

Cooking fats

360 mg/100 g

Non-alcoholic beverages (including dairy analogue and milk-based drinks)

80 mg/100 ml

Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Processed cereal-based foods and baby foods for infants and young children as defined in Regulation (EU) No 609/2013

200 mg/100 g

 

Fruit/vegetable puree

100 mg/100 g

▼M71

Schizochytrium sp. (FCC-3204) oil

Specified food category

Maximum levels of DHA

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the microalgae Schizochytrium sp.’.

The labelling of food supplements containing Schizochytrium sp. (FCC-3204) oil shall bear a statement that they should not be consumed by infants and children under 3 years of age.

 

 

Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Food supplements as defined in Directive 2002/46/EC for the general population above 3 years of age

1 g/day

▼M25

Schizochytrium sp. oil

Specified food category

Maximum levels of DHA

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the microalgae Schizochytrium sp.’

 

 

Dairy products except milk-based drinks

200 mg/100 g or for cheese products 600 mg/100 g

Dairy analogues except drinks

200 mg/100 g or for analogues to cheese products 600 mg/100 g

Spreadable fat and dressings

600 mg/100 g

Breakfast cereals

500 mg/100 g

Food Supplements as defined in Directive 2002/46/EC

250 mg DHA/day for general population

450 mg DHA/day for pregnant and lactating women

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

250 mg/meal

Milk-based drinks and similar products intended for young children

200 mg/100 g

Processed cereal-based foods and baby foods for infants and young children as defined in Regulation (EU) No 609/2013

Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen

Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Implementing Regulation (EU) No 828/2014

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Bakery products (breads, rolls, and, sweet biscuits)

200 mg/100 g

Cereal bars

500 mg/100 g

Cooking fats

360 mg/100 g

Non-alcoholic beverages (including dairy analogue and milk-based drinks)

80 mg/100 ml

Fruit/vegetable puree

100 mg/100 g

▼M52

Schizochytrium sp. (T18) oil

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the microalgae Schizochytrium sp.’.

 

 

Dairy products except milk-based drinks

200 mg/100 g or for cheese products 600 mg/100 g

Dairy analogues except drinks

200 mg/100 g or for analogues to cheese products 600 mg/100 g

Spreadable fats and dressings

600 mg/100 g

Breakfast cereals

500 mg/100 g

Food supplements as defined in Directive 2002/46/EC

250 mg DHA/day for general population

450 mg DHA/day for pregnant and lactating women

Total diet replacement for weight control as defined in Regulation (EU) No 609/2013 and meal replacements for weight control

250 mg/meal

Milk-based drinks and similar products intended for young children

200 mg/100 g

Foods intended to meet the expenditure of intense muscular effort, especially for sportsmen

Foods bearing statements on the absence or reduced presence of gluten in accordance with the requirements of Commission Implementing Regulation (EU) No 828/2014

Foods for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Bakery products (breads, rolls and, sweet biscuits)

200 mg/100 g

Cereal bars

500 mg/100g

Cooking fats

360 mg/100 g

Non-alcoholic beverages (including dairy analogue and milk-based drinks)

80 mg/100 ml

Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

Processed cereal-based foods and baby foods for infants and young children as defined in Regulation (EU) No 609/2013

200 mg/100 g

Fruit/vegetable puree

100 mg/100 g

▼M65

Schizochytrium sp. (WZU477) oil

Specified food category

Maximum levels of DHA

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Oil from the microalgae Schizochytrium sp.’

 

Authorised on 16 May 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Progress Biotech bv, Canaalstaete, Kanaalweg 33, 2903LR Capelle aan den Ijssel, the Netherlands.

During the period of data protection, the novel food is authorised for placing on the market within the Union only by Progress Biotech bv unless a subsequent applicant obtains authorisation for that novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Progress Biotech bv.

End date of the data protection: 16 May 2026 (5 years).

Infant formula and follow-on formula as defined in Regulation (EU) No 609/2013

In accordance with Regulation (EU) No 609/2013

▼M57

Selenium-containing yeast (Yarrowia lipolytica) biomass

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘selenium-containing yeast (Yarrowia lipolytica) biomass’.

The labelling of food supplements containing selenium-containing yeast (Yarrowia lipolytica) biomass shall bear a statement that the food supplements should not be consumed by infants and children under 4 years of age/children under 7 years of age/children under 11 years of age/children and adolescents under 18 years of age (3).

 

 

Food supplements as defined in Directive 2002/46/EC (12), excluding food supplements for infants and children under 4 years of age

50 mg/day for children from 4 to 6 years of age, resulting in 10 μg of selenium per day

100 mg/day for children from 7 to 10 years of age, resulting in 20 μg of selenium per day

500 mg/day for adolescents from 11 to 17 years of age, resulting in 100 μg of selenium per day

800 mg/day for adults, resulting in 160 μg of selenium per day

▼M20 M36 M62 M104

3'-Sialyllactose (3'-SL) sodium salt

(microbial source)

Specified food category

Maximum levels (expressed as 3'-Sialyllactose)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘3'-Sialyllactose sodium salt’.

The labelling of food supplements containing 3'-Sialyllactose sodium salt shall bear a statement that they should not be consumed:

a)  if foods containing added 3'-Sialyllactose sodium salt are consumed the same day.

b)  by infants and young children

 

Authorised on 18 February 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food 3'-sialyllactose sodium salt is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S.

End date of the data protection: 18 February 2026.

Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products

0,25 g/L

Unflavoured fermented milk-based products

0,25 g/L (beverages)

0,5 g/kg (products other than beverages)

Flavoured fermented milk-based products including heat-treated products

0,25 g/L (beverages)

2,5 g/kg (products other than beverages)

Beverages (flavoured drinks, excluding drinks with a pH less than 5)

0,25 g/L

Cereal bars

2,5 g/kg

Infant formula as defined in Regulation (EU) No 609/2013

0,2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined in Regulation (EU) No 609/2013

0,15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based food and baby food for infants and young children as defined in Regulation (EU) No 609/2013

0,15 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

1,25 g/kg for products other than beverages

Milk-based drinks and similar products intended for young children

0,15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Total diet replacement foods for weight control as defined in Regulation (EU) No 609/2013

0,5 g/L (beverages)

5 g/kg (products other than beverages)

Food for special medical purposes as defined in Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food Supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

0,5 g/day

▼M122

3′-Sialyllactose (‘3′-SL’) sodium salt

(produced by derivative strains of E. coli BL21(DE3))

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘3′-Sialyllactose sodium salt’.

The labelling of food supplements containing 3′-Sialyllactose (3′-SL) sodium salt shall bear a statement that

(a)  they should not be consumed by children under 3 years of age;

(b)  they should not be used if other foods containing added 3′-sialyllactose sodium salt are consumed the same day.

 

Authorised on 6 February 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: ‘Chr. Hansen A/S’, Boege Allé 10-12, 2970 Hoersholm, Denmark. During the period of data protection, the novel food 3′-Sialyllactose sodium salt is authorised for placing on the market within the Union only by Chr. Hansen A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Chr. Hansen A/S’.

End date of the data protection: 6 February 2028.

Infant formula as defined under Regulation (EU) No 609/2013

0,28 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

0,28 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based foods for infants and young children and baby foods for infants and young children as defined under Regulation (EU) No 609/2013

0,28 g/L or 0,28 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Milk based drinks and similar products intended for young children

0,28 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Foods for special medical purposes for infants and young children as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than 0,28 g/L or 0,28 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer.

Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food Supplements as defined in Directive 2002/46/EC, for the general population, excluding infants and young children

0,7 g/day

▼M135

3′-Sialyllactose (3′-SL) sodium salt

(produced using a derivative strain of E. coli W (ATCC 9637))

Specified food category

Maximum levels (expressed as 3-Sialyllactose)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘3′-Sialyllactose sodium salt’.

The labelling of food supplements containing 3′-Sialyllactose (3′-SL) sodium salt shall bear a statement that they should not be consumed:

(a)  if foods containing added 3′-Sialyllactose sodium salt are consumed on the same day;

(b)  by children under 3 years of age.

 

Authorised on 30 April 2024.

This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Kyowa Hakko Bio Co., Ltd, Nakano Central Park South, Nakano 4-10-2, Nakano-ku Tokyo, 164-0001 Japan. During the period of data protection, the novel food 3′-sialyllactose sodium salt produced using a derivative strain of E. coli W (ATCC 9637) is authorised for placing on the market within the Union only by Kyowa Hakko Bio Co., Ltd, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Kyowa Hakko Bio Co., Ltd.

End date of the data protection: 30 April 2029.

Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products

0,25 g/L

Unflavoured fermented milk-based products

0,25 g/L (beverages)

0,5 g/kg (products other than beverages)

Flavoured fermented milk-based products including heat-treated products

0,25 g/L (beverages)

2,5 g/kg (products other than beverages)

Beverages (flavoured drinks, excluding drinks with a pH less than 5)

0,25 g/L

Cereal bars

2,5 g/kg

Infant formula as defined under Regulation (EU) No 609/2013

0,2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

0,15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based food and baby food for infants and young children as defined under Regulation (EU) No 609/2013

0,15 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

1,25 g/kg for products other than beverages

Milk based drinks and similar products

0,15 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013

0,5 g/L (beverages)

5,0 g/kg (products other than beverages)

Food for special medical purposes as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

1,0 g/day

▼M60

6’-Sialyllactose (6’-SL) sodium salt

(microbial source)

Specified food category

Maximum levels (expressed as 6’-Sialyllactose)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘6’-Sialyllactose sodium salt’.

The labelling of food supplements containing 6’-Sialyllactose (6’-SL) sodium salt shall bear a statement that they should not be consumed:

a)  if foods containing added 6’-Sialyllactose sodium salt are consumed on the same day.

b)  by infants and young children

 

Authorised on 17 February 2021. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark. During the period of data protection, the novel food 6’-sialyllactose sodium salt is authorised for placing on the market within the Union only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S.

End date of the data protection: 17 February 2026.

Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products

0,5 g/L

Unflavoured fermented milk-based products

0,5 g/L (beverages)

2,5 g/kg (products other than beverages)

Flavoured fermented milk-based products including heat-treated products

0,5 g/L (beverages)

5,0 g/kg (products other than beverages)

Beverages (flavoured drinks, excluding drinks with a pH less than 5)

0,5 g/L

Cereal bars

5,0 g/kg

Infant formula as defined under Regulation (EU) No 609/2013

0,4 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

0,3 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based food and baby food for infants and young children as defined under Regulation (EU) No 609/2013

0,3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

2,5 g/kg for products other than beverages

Milk based drinks and similar products intended for young children

0,3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013

1,0 g/L (beverages)

10,0 g/kg (products other than beverages)

Food for special medical purposes as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food Supplements as defined in Directive 2002/46/EC, excluding food supplements for infants and young children

1,0 g/day

▼M115

6’-Sialyllactose (‘6-SL’) sodium salt

(produced by derivative strains of E. coli BL21(DE3))

Specified food category

Maximum levels

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘6′-Sialyllactose sodium salt’.

The labelling of food supplements containing 6′-Sialyllactose (6′-SL) sodium salt shall bear a statement that

(a)  they should not be consumed by children under 3 years of age;

(b)  they should not be consumed if other foods containing added 6′-sialyllactose sodium salt are consumed the same day.

 

Authorised on 4 June 2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: ‘Chr. Hansen A/S’, Bøge Allé 10-12, 2970 Hoersholm, Denmark. During the period of data protection, the novel food 6′-Sialyllactose sodium salt is authorised for placing on the market within the Union only by Chr. Hansen A/S unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of ‘Chr. Hansen A/S’.

End date of the data protection: 4 June 2028.

Infant formula as defined under Regulation (EU) No 609/2013

0,70 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

0,70 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based foods for infants and young children and baby foods for infants and young children as defined under Regulation (EU) No 609/2013

0,70 g/L or 0,70 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Milk based drinks and similar products intended for young children

0,70 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Foods for special medical purposes for infants and young children as defined under Regulation (EU) No 609/2013

In accordance with the particular nutritional requirements of the infants and young children for whom the products are intended but in any case not higher than 0,70 g/L or 0,70 g/kg in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer.

Foods for special medical purposes as defined under Regulation (EU) No 609/2013 excluding foods for infants and young children

In accordance with the particular nutritional requirements of the persons for whom the products are intended

Food Supplements as defined in Directive 2002/46/EC, for the general population, excluding infants and young children

1,8 g/day

▼M127

6′-Sialyllactose (6′-SL) sodium salt

(produced by derivative strain of E. coli W (ATCC 9637))

Specified food category

Maximum levels (expressed as 6-Sialyllactose)

The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘6′-Sialyllactose sodium salt’.

The labelling of food supplements containing 6′-Sialyllactose (6′-SL) sodium salt shall bear a statement that they should not be consumed:

(a)  if foods containing added 6′-Sialyllactose sodium salt are consumed on the same day;

(b)  by children under 3 years of age.

 

Authorised on 13.11.2023. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.

Applicant: Kyowa Hakko Bio Co., Ltd, 1-9-2, Otemachi, Choyoda-ku Tokyo, 100-0004, Japan. During the period of data protection, the novel food 6′-sialyllactose sodium salt produced by derivative strain of E. coli W (ATCC 9637) is authorised for placing on the market within the Union only by Kyowa Hakko Bio Co., Ltd, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Kyowa Hakko Bio Co., Ltd.

End date of the data protection: 13.11.2028.

Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products

0,5 g/L

Unflavoured fermented milk-based products

0,5 g/L (beverages)

2,5 g/kg (products other than beverages)

Flavoured fermented milk-based products including heat-treated products

0,5 g/L (beverages)

5,0 g/kg (products other than beverages)

Beverages (flavoured drinks, excluding drinks with a pH less than 5)

0,5 g/L

Cereal bars

5,0 g/kg

Infant formula as defined under Regulation (EU) No 609/2013

0,4 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Follow-on formula as defined under Regulation (EU) No 609/2013

0,3 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Processed cereal-based food and baby food for infants and young children as defined under Regulation (EU) No 609/2013

0,3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

2,5 g/kg for products other than beverages

Milk based drinks and similar products

0,3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer

Total diet replacement foods for weight control as defined under Regulation (EU) No 609/2013

1,0 g/L (beverages)

10,0 g/kg (products other than beverages)

Food for special medical purposes as def